TW202427B - - Google Patents

Download PDF

Info

Publication number
TW202427B
TW202427B TW080109166A TW80109166A TW202427B TW 202427 B TW202427 B TW 202427B TW 080109166 A TW080109166 A TW 080109166A TW 80109166 A TW80109166 A TW 80109166A TW 202427 B TW202427 B TW 202427B
Authority
TW
Taiwan
Prior art keywords
compound
group
fan
gas
item
Prior art date
Application number
TW080109166A
Other languages
Chinese (zh)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of TW202427B publication Critical patent/TW202427B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/27Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring

Description

Μ 024S7 五、發明説明(/ ) 本發明乃有關3 -環烷丙醯胺,其齧,其製法,其藥劑 組成物及以其做為藥物之應用。 本發明乃提供化合物(I )及其加齡發:Μ 024S7 V. Description of the invention (/) The present invention relates to 3-cycloalkylpropionamide, its bite, its preparation method, its pharmaceutical composition and its application as a medicine. The present invention provides compound (I) and its aging hair:

I) 式中Ri偽C3-6環烷基; R 2傜氫原子或C i .. 3烷基; R3 ,R6及R7可為相同或不同,偽氫原子, 鹵原子,腈基,叠氮基,-N02,直鏈或分枝Ci_ 6烷 基,直鏈或分枝Ci_ 6烷氣基,Cl - s烷硫基,COR' 基(其中R’係羥基,Ci- 3烷基或烷氣基),或選自 -(CH2)m-CF3, -0-(CH2)m-CF3, -S-(CH2)m -CF3,/F -CF2-Hal, -0-CF2-Hal, -(CF2)n -C ——Hal1^Hal, (請先閲讀背而之注意事項#填寫本頁) 裝· 訂- 經濟部屮央栉準·x;cx工消炸合作社印51I) in the formula Ri pseudo C3-6 cycloalkyl; R 2 hydrogen atom or C i .. 3 alkyl; R3, R6 and R7 may be the same or different, pseudo hydrogen atom, halogen atom, nitrile group, azide Group, -N02, straight-chain or branched Ci_6 alkyl group, straight-chain or branched Ci_6 alkyl gas group, Cl-s alkylthio group, COR 'group (wherein R' is a hydroxyl group, Ci-3 alkyl or alkyl group) Gas group), or selected from-(CH2) m-CF3, -0- (CH2) m-CF3, -S- (CH2) m -CF3, / F -CF2-Hal, -0-CF2-Hal,- (CF2) n -C ——Hal1 ^ Hal, (please read the back-end precautions # fill in this page) Binding · Order-Ministry of Economic Affairs 屮 央 栉 准 · x; cx 工 消 炸 炸 社 社 印 51

-〇-(CF2)n -C F /F -Hal” -S-(CF2)n -C — Hal, Hal, 'Hal, 及-0-(CF2)n-CF-CF3, Hal, 3 - 本紙5良尺度逍用中Η國家標準(CNS)fM規^(210x297公龙) 五、發明説明(> 中 其 或 2 11 偽 Π 3 或 及 及 Λ fi Π 6 或 \J/ 子 原 鹵 為 各 同 不 或 同 相 為 可 起 如 偽 7 R 及 型 構 異 變 互 的 有 0 I ί 物 合 化 含 包 明 發 本 是 的 。解 者瞭 述須 前 中 〇 文基 本己 環 或 基 戊 環 基 丁 環 基 丙 環 指 基 烷 環 基直 丙或 異基 或丙 基異 丙或 、基 基丙 乙 、 、基 基乙 甲 、 指基 基甲 烷是 3 如 - 例 1 基 C烷 言 6 所 此-在C1 基 己 或 基 戊 基 丁 之 枝 分 或 鏈 或 ' 基 氣 丙 ' 基 氣 乙 / 基 氣 甲 是 如 例 基 氣 烷 S異 基或 S基。 e硫豸 或¾硫 基Θ己 罾基豸 戊㈤基 -乙吧 基 戊 0 £ 、 丁 Μ基 2 甲¾ 双是T 殳如⑦ 或]*分 0 ^ Μ ^ ^或½直,❻或 6 基 、 «1-基 丙C1硫 異 丙 和 齡或 〇 機 , 子有鹽 原或銨 碘機及 或無 、 溴加鎂 、添 、 氛自鈣 '生 、 氟衍鋰 含乃 、 包鹽鉀 素龄 , 窗加納 如 0 物 碾 如 胺 機 有 鹽胺 之甲 丨如 (請先閲筇背而之注意事項典填寫本頁) 甲 丙 { 、 三胺及 、 己酸 胺琛胺 醇二姐 乙 , -甲啶酸 二吡胺 N-基精 N 甲 , 、,酸 胺啶胺 乙吡賴 三 、 . ' 胺因 胺醇卡 乙乙魯 二 、裨 、烷 , 胺甲胺 甲胺苄 三 、 £ 啉 基 甲 6 R » ’子 5 R 原 4S R 或 ,溴 3 R 中氮 式 , 為氣 物 -合氫 化係 0 之 , 胺佳同 糖較不 涵明或 基發同 甲本相 N-為 及 可乙 7 , 本紙法尺度边用中《«家楳準(CNS)V 4規格(210x297公坺) 經尔部屮央標準·/(.JA工消奸合作杜印3i ^02427 Λ fi __HJJ_ 五、發明説明U ) 基,第三丁基,甲氧基,甲硫基,三氟甲基,三氟甲氧 基,三氟甲硫基,五氟乙基,溴二氟甲氧基,乙藍,羥 羧基,甲氣羰基,硝基,叠氮基或腈基‘;或R4及R5 — 起係-0-CH2 -0-,而3 ,R4及R7如前述;r2傜氳原子 或甲基,及1^如前述者。 依本發明待佳之化合物乃式中 R 1偽環丙基; R2偽氫原子或甲基; R3 ,R4 ,RS ,R6及R7可為相同或不同,偽氫,氟, 氯或碘原子,甲基,-N02或- CF3g。 尤佳之化合物包含: 1-(4-硝苯胺基甲醛)-2-環丙基-2-氣丙腈; 1-(4-氛苯胺基甲醯)-2-環丙基-2-氣丙腈; 1-(4 -氛-3-甲苯胺基甲醯)-2 -環丙基-2-氣丙腈; 1- (3-甲基-4-三氟甲苯胺基甲醛)-2-琛丙基-2-氣丙腈; 1-(4 -氰-3-甲苯胺基甲醛)-2 -琿丙基-2-氣丙腈; 及其加齡鹽。 本發明化合物例如可依下列製程製得,本發明亦包含 此等製程。 前述化合物(I)例如可由化合物(II) (請先閲請背而之注意节碩再艰寫本頁) 裝. 線.-〇- (CF2) n -CF / F -Hal "-S- (CF2) n -C — Hal, Hal, 'Hal, and -0- (CF2) n-CF-CF3, Hal, 3-Original paper 5 Good standards for the use of China National Standards (CNS) fM regulations ^ (210x297 male dragons) V. Description of the invention (> where it is either 2 11 pseudo Π 3 or and Λ fi Π 6 or \ J / sub raw halogen for each The same or not in the same phase can be used as a pseudo 7 R and a configurational alteration of each other. There is a 0 I ί compound with the inclusion of the original version. The interpreter explained the basic hex ring or pentyl ring group. Butylcyclopropane refers to alkane cyclopropyl straight or isopropyl or propyl isopropyl, propylpropyl ethyl, propylethyl methyl, acetylmethyl methane is 3 as-Example 1 yl C alkyl words 6 so -Branches or chains of C1 Hexyl or Pentylbutyl or ‘Base Gas C’ Base Gas B / Base Gas A is as example base gas alkyl S iso- or S-base. E thiopropyl or thiothio Θhe漾 基 豸 pentyl-ethyl pentyl 0 £, 丁 Μ 基 2 A ¾ Double is T 殳 like ⑦ or] * points 0 ^ Μ ^ ^ or ½ straight, ❻ or 6 bases, «1-ylpropyl C1 Thioisopropyl and age or 〇 machine, the child has salt or Ammonium iodine machine and or not, bromine plus magnesium, add, atmosphere from calcium ', calcium fluoride, lithium salt, potassium salt age, window Ghana, such as 0, such as amine machine, salt amine, such as (please first (Read this page to fill in the code of precautions and fill out this page) Methylpropionate (, triamine and, hexanoic acid, ammonium amine, alcohol, and diethylacetate, -dipicolinate N-methyl nicotinic acid, methidine, dimethoxine,, amine pyridine amine Ethylpyridine,. 'Amininol, carbediludi, bis, alkane, amine, methylamine, benzyl, £, quinolinyl, methyl 6 R »' Sub 5 R, original 4S R or, bromine 3 R, middle nitrogen The formula is the gas-combined hydrogenation system 0, the amine good homosaccharide is less specified or the base is the same as the original phase N- 为 和 可 乙 7, this paper method scale is used in the "« Jiashu standard (CNS) V 4 Specification (210x297 gong) Jingerbeiyang Standard · / (. JA 工 工 殺 業 Cooperation Duin 3i ^ 02427 Λ fi __HJJ_ V. Description of invention U) group, third butyl, methoxy, methylthio, Trifluoromethyl, trifluoromethoxy, trifluoromethylthio, pentafluoroethyl, bromodifluoromethoxy, ethyl blue, hydroxycarboxy, methyl carbonyl, nitro, azido or nitrile '; Or R4 and R5 — Starting from -0-CH2-0-, and 3, R4 and R7 are as described above; r2 is a atom or methyl group, and 1 ^ is as described above. The compound to be optimized according to the present invention is the formula R 1 pseudocyclopropyl; R2 pseudo hydrogen atom or methyl; R 3, R 4, RS, R 6 and R 7 may be the same or different, pseudo hydrogen, fluorine, chlorine or iodine atom, A Base, -N02 or -CF3g. Particularly preferred compounds include: 1- (4-nitroanilin formaldehyde) -2-cyclopropyl-2-fluoropropionitrile; 1- (4-nitroaniline formamide) -2-cyclopropyl-2-fluoro Propiononitrile; 1- (4-Amino-3-toluylaminoformamide) -2-cyclopropyl-2-gasopropionitrile; 1- (3-methyl-4-trifluorotoluylaminoformaldehyde) -2 -Chenpropyl-2-gas propionitrile; 1- (4-cyano-3-tolylcarbaldehyde) -2-Hunpropyl-2-gas propionitrile; and its ageing salts. The compounds of the present invention can be prepared according to the following processes, for example, and the present invention also includes such processes. The aforementioned compound (I) can be installed, for example, by compound (II) (please read first, please pay attention to the details and write this page). Thread.

本紙5lt尺度边用中國困家楳毕(CNS) 規格(210x297公沒:) .024^7 Λ(; '___Π_6_ 五、發明説明(♦) (式中R 2 , R 3 , R 4 , R 5 , R S及R 7如前述)和氫化納,必 要時在觸媒如咪唑之存在下反應,接著使所得中間體和 化合物(in)反應得之,The 5lt scale of this paper uses the Chinese Sleepy Family (CNS) specifications (210x297): .024 ^ 7 Λ (; '___ Π_6_ V. Invention description (♦) (where R 2, R 3, R 4, R 5 , RS and R 7 as described above) and sodium hydride, if necessary in the presence of a catalyst such as imidazole, and then the resulting intermediate and compound (in) are reacted,

Hal -CO R 1 (III) 式中Hal偽鹵原子,而Ri如前述。 化合物(I I)和氫化納之反應較佳為在無水有機溶劑如四 氫呋喃中進行。 化合物(I I)方便上是由化合物(I V ) (請先閲請背而之注意事項#堝寫本頁) 中 式Hal-CO R 1 (III) where Hal is a pseudo halogen atom, and Ri is as described above. The reaction of the compound (III) and sodium hydride is preferably carried out in an anhydrous organic solvent such as tetrahydrofuran. The compound (I I) is conveniently composed of the compound (I V) (please read the back-to-back precautions first #pot write this page) Chinese

物 合 化 和 \)/ 述 前 如 7 R 及 裝- 訂 線· 得 而 應 反 物 生 衍 能 官 其Compounding and \) / As mentioned before 7 R and binding-binding line

經濟部+央標準而:5工消价合作杜印32. 在 , 為下 佳在 較存 應之 反胺 之亞 物二 生化 衍ιβ( 能基 笸己 其琛 或二 V;或 ΪΙΚ 合亞 化二 和化 Ivjlg i基 合丙 化異 二 或 喃 呋 氳 四 -_ i 溶合 機化 有用 水採 無若 於 物 生 衍 能 官 行 進 中 烷 甲 氛 氮 乙 氮 是 如 例 本紙51尺度边用中a國家烊準(CNS)TM規格(210x29V公甘) 五、發明説明(·Γ ) 其可例如由氰乙酸和五氣化磷化磷現場反應而得。 化合物(II)之製法可參照A.Nohara.T· Ishiguro等氏在 "藥物化學期刊",1 9 8 5年2 8 ( 5 )期,5 5 9 - 5 6 6頁所述如下 列之方法製得:The Ministry of Economic Affairs and the Central Standard: 5 industrial and low-cost cooperation Du Yin 32. In, for the next best in the relatively existing anti-amine sub-biological chemical derivative ι β (Neng Ji Sui Jichen or two V; or ΪΙΚ Heya Idi and Ivjlg i-propylated heterodi-or furfural tetra-_i fusing organically with water and using it as if it were traveling in the bio-generating energy officer. Alkane, nitrogen, and nitrogen are as examples. Use the Chinese National Standard (CNS) TM specification (210x29V). 5. Description of the invention (· Γ) It can be obtained, for example, from the on-site reaction of cyanoacetic acid and penta-vaporized phosphide. The preparation method of compound (II) can be referred to A. Nohara.T · Ishiguro et al. Were prepared in the following way in the "Journal of Medicinal Chemistry", 1 9 8 5 2 8 (5), pages 5 5 9-5 6 6:

CHOCHO

CHOCHO

〇_ / NHCOCH2CN 經濟部屮央標準·"JA工消奸合作杜印虹 用於前述製程之化合物〔IV_>—般為已知之産物,或可依 已知製法,先重氮化,然後還原對應之硝基苯胺得之。 所用之硝基苯胺之製法例如可參閲TP.Sura等氏”合成通 訊", 1988年 18(16-17)期,2161-5頁。 某些苯胺ClVj可依歐洲專利206, 951號所逑的方法製備 ,或由對應的硝基苯(某些為已知)還原而得;但某些 硝基苯為新穎,可依下面的實施例所述之方法製得。 化合物(Π在本質上是酸性的。化合物(U之加鹺鹽較佳 為由大約化學計置比率的無機或有機鹼和化合物tD反應 而得。此鹽可由對應之酸性化合物直接製得,不必分離 出中間體。 本發明化合物具有價佰之铤理性質,值得一提的是其 顯砮的消炎活性。其可利用特殊的抗原阻缓免疫细胞之活 性而抑制因刺激物引起的發炎.及延羥之過敏反應。 在實驗部分中將進一步説明此等性質。 (請先閲讀背而之注意事項#碼寫本頁) 裝- 訂_ 線' 本紙51c尺度边用中a Η家详1MCNS) Ή規仂(210x297公放) 024^? 五、發明説明(k) Λ G Π 6 做 鹽 鹼 加 可 許 Ht 〇 理 物藥 藥其 為及 用I) 可飢 鹽合 鹼化 加述 其前 及以 ίυ關 物有 合又 化明 是發 於本 中 式 為 物 合 化 佳 較 〇 之 用物 應 _ 之為 物用 藥可 為 及 氨 氟 氫 傜 同 不 或 同 相 基 甲 子 原 碘 或 溴 基基 甲氧 氟甲 三氟 ,二 基溴 硫 , 甲基 ,乙 基氟 氧五 甲 , -基 基硫 丁甲 三氟 第三 基基 乙氣 甲 , 氟醯 三乙 - 基 ο , I 甲 基傜或 羰起子 羥一原 基 腈 q 或R7 基及 m6 R 叠 3 基 R 硝而 基0- 羰- 2 氣 Η C 甲 -〇_ / NHCOCH2CN Ministry of Economic Affairs Standards " JA Gongxiao cooperation Du Yinhong The compound used in the aforementioned process [IV_ > is generally a known product, or it can be diazotized according to the known manufacturing method, and then reduced corresponding Nitroaniline was obtained. For the preparation method of the nitroaniline used, for example, see TP. Sura et al., "Synthetic Communications", 18 (16-17), 1988, page 2161-5. Some aniline ClVj can be based on European Patent No. 206, 951 It is prepared by the method of or obtained from the reduction of the corresponding nitrobenzene (some are known); but some nitrobenzene is novel and can be prepared according to the method described in the following examples. Compound (Π in essence It is acidic. The compound (U salt added with U is preferably obtained by reacting an inorganic or organic base with an approximate stoichiometric ratio of compound tD. This salt can be prepared directly from the corresponding acidic compound without having to isolate the intermediate. The compound of the present invention has a valuable property, and it is worth mentioning that its anti-inflammatory activity is obvious. It can use special antigens to slow down the activity of immune cells and inhibit inflammation caused by irritants. These properties will be further explained in the experimental part. (Please read the back-end notes #code to write this page) Binding-order _ line '51c scale side paper used in the paper a Η 家 見 1MCNS) Ή Regulations (210x297 Public) 024 ^? V. Description of the invention (k) Λ G Π 6 Do salt and alkali plus permissible Ht 〇Physical medicine and its use and use I) It can be hungry, salt and alkalinization, and it is added to the previous and it is clear that it is made in this Chinese formula for physical and chemical. 〇The substance should be the same as the substance. The substance can be different from or in the same phase as amflurohydrogen. It is based on proton iodine or bromomethoxytrifluoromethanetrifluoride, diyl bromide sulfur, methyl, ethylfluorooxypentamethyl. , -Yl thiobutane trifluoro third yl ethyl gas methyl, fluoro acetyl triethyl-yl, I methyl ester or carbonyl group hydroxymonoorthonitrile q or R7 group and m6 R stack 3 group R nitrile Radical 0- carbonyl- 2 gas H C A-

者 述 前 如 1Χ R 或 及 述 前 如 氫 傜 (請先閲請背而之注意事領#填寫本頁) 中 式 為 物 合 化 佳 特 之 物 藥 為 做 可 明 發 本 依 基 丙 琛 係 基及 甲 6 R 或 , 子 5 R 原 ,0 4 R 偽 , 及 或 氛 氟0 俱 同 不 或 同 相 者 3 F : C -- 有 或物 , 合 2 化 No佳 ,尤 基之 甲物 ,_ 子為 原做 碘 § WB tu.- to? 丙丙 氣«; I I 2 2 f I 基基 丙丙 琛琛 I -2 2 I I \J/ \J/ 酯酷 甲甲 基基 胺胺 苯苯 硝氰 經濟部十央標準而:^工消价合作社印驭 丙 ; 氣; 腈2-腊 丙$丙m ^ m - 丙 --2環-2 基2-基 丙)-丙 琿醛環 嫌 - 2 甲 2 )-基}-醯胺趦 甲苯甲 基甲基 胺氟胺 苯三苯 甲 彳 甲 - - - 7甚7 氮甲« 0 甲 基 胺 苯 甲 槪 三 - 4- 基 甲 硝 丙 氣- 2- 基 丙 環 鹽 齡 加 其 及 本紙5fc尺度逍用中a Η家榀準(CNS) TM規格(210x297公甘) 2024V? Λ 0 _Π_6_ 五、發明説明(7 ) · 此等物可例如用於治療風溼性關節炎及免疫性或非免 疫性的慢性發炎(例如移植-對-受移植者疾病,移植反 應,葡萄膜炎)。 通常之剤量端賴於所用化合物.處理之患者及病況而 定,每日口服之新量例如為〇.1毫克至2QG毫克。 本發明尚提供藥劑组成物,其中包含至少一種前述化 合物(I域具藥理許可加鹸鹽,配合一種或多種藥劑攜體 及/或賦形劑。 用為藥物時,可將化合物ω及其加齡鹽諝製成口服劑 ,直腸劑或腸外用劑。 此等藥劑可例如是固態或液態,呈常用於人類醫藥之 形式,例如厚錠片或被覆錠片,腰囊(包含有謬膠囊), 顆粒劑,柱栓_,溶液,例如注射溶液,凡此種種均可 依常法製備之,亦即使活性成分混合常用於藥劑組成物 之賦形劑,如滑石,阿拉伯樹膠,澱粉,乳糖,硬脂酸 椰子油,水性或非水性攜體,動物或植物脂,石皤衍生物 二醇類各種潤溼,分散或乳化剤及防腐劑。 本發明尚提供治療人類或動物之風恧性 關節炎及免 疫性或非免疫性之慢性發炎之方法,偽服用有效量的 前述化合物(I域其第理許可加_邇。 本發更有關新類之化合物(JI): 本紙ft尺度逍用中國國家详準(CNS) ΤΜ規格(210x297公龙) (請先閲-^背而之注*事項#塥寫本页) 裝· 線· 024¾^五、發明説明(?)If the preface is like 1Χ R or the preface is like hydrogen 傜 (please read first and back to the attention of the matter # fill in this page) The Chinese medicine is the compound medicine of Jiate for the purpose of making it clear. Base and A 6 R or, sub 5 R original, 0 4 R pseudo, and or fluorinated 0 are the same or not in phase 3 F: C-there is or something, it is better to combine No. 2 and Yuki, _ The child is the original iodine § WB tu.- to? Propyl propane gas «; II 2 2 f I 基基 丙 丙 琛琛 I -2 2 II \ J / \ J / Ester methyl methylaminoamine benzene The nitrocyanine Ministry of Economy's Shiyang standard is: ^ Industry and Consumer Price Cooperatives Yinyu C; Gas; Nitrile 2-Rapron $ propyl m ^ m-Propane-2 ring-2 yl 2-ylpropanyl) -propanal ring -2 A 2) -yl} -acrylamide toluene methyl methylamine fluoroamine benzotriazole---7 even 7 nitromethine «0 methylamine benzotriamine-4-ylmethylnitropropyl Gas-2-ylpropane salt age plus its 5fc scale for paper use in the middle of a family of standard (CNS) TM specifications (210x297 g) 2024V? Λ 0 _Π_6_ V. Description of the invention (7) · These can be For example for the treatment of rheumatoid arthritis and immunity or Chronic inflammation of immunological (e.g., graft - to - graft disease in a subject, transplantation reactions, uveitis). The usual dosage depends on the compound used. The patient to be treated and the condition, the new daily oral dosage is, for example, 0.1 mg to 2QG mg. The present invention also provides a pharmaceutical composition, which contains at least one of the aforementioned compounds (the I domain is pharmacologically approved to be added with an emu salt, in combination with one or more pharmaceutical carriers and / or excipients. When used as a medicine, the compound ω and its Age salt can be made into oral preparation, rectal preparation or parenteral preparation. These preparations can be solid or liquid, for example, in the form commonly used in human medicine, such as thick tablets or coated tablets, waist capsule (including false capsules) , Granules, plugs, solutions, such as injection solutions, all of these can be prepared according to the usual method, even if the active ingredients are mixed with excipients commonly used in pharmaceutical compositions, such as talc, gum arabic, starch, lactose, Coconut stearate oil, aqueous or non-aqueous carriers, animal or vegetable fats, various derivatives of scallion derivatives glycols, wetting, dispersing or emulsifying agents and preservatives. The present invention also provides treatment of wind-induced arthritis in humans or animals And immune or non-immune chronic inflammation method, pseudo-administer an effective amount of the aforementioned compound (I domain plus its first permission plus _ 俩. This is more relevant to the new class of compounds (JI): this paper ft scale With China National Long quasi (CNS) ΤΜ size (210x297 male dragon) (Please read - Note * ^ back while the dry clay lump matters # write the page) installed · line · 024¾ ^ V. invention is described in (?)

P RP R

Λ (i Π fi 丄: R„ II) 經濟部屮央栉準工消"合作社印31 (式中R2 ,R3 ,iU ,R5 ,1^6及117如前述者,其為新穎 工業産物,待別是可做為製造化合物I之中間體。 較佳為化合物(I I),式中R 3 , R 6及ϋ 7各為氫原子:I 偽甲基;而Rs如前述但不是氮原子或甲基者。 玆以非限制本發明範圍之實施例説明: 窗旃例 例 1 1-(4-三氟甲苯胺基甲醯)-2-琛丙基-2-氣丙腈; 步驟A :4 -三氟甲基氮乙醯替苯胺 不冷卻,在8.6克,1.01莫耳氰乙截替苯胺及13. 5毫 升,0.1莫耳4-(三氟甲基)苯胺/100*升乾燥四氩呋喃 溶液中《拌加入16. 4毫升,0.1G5其耳二異丙基硝化二 亞胺,壓10分鐘。添加時,溶液溫度由20°上升至60°C 。在室溫攪伴混合物16小時,過濾,Μ發濾液蒸乾固, 得固態殘餘物。使之懸浮在1 〇 〇奄升乙醉中,在室溫佾 拌1小時,以5 0 *升乙醉,2 X 1 0 0薨升二氮甲烷及2 X 1 〇 〇毫升己烷洗。在6 0 °C宾空乾燥3小時,得1 8 . 8 5克症 物(産率83% ),熔點195-6°C (無色結晶)。 10- 本紙5良尺度逍用中SH家楳準(CNS)fM規格(210x297公釐) (請先閲請背而之注意^項#项寫本頁) Μ Λ Π 6 五、發明説明(9 ) 步驟B: 1 - ( 4-三氟甲苯胺基甲醯)-2-環丙基-2-氣丙腈 在乾燥氮氣下,以8 0 %氫化納之油分散液(Q . 8 8克, 0.0 2 8 6莫耳)處理3·0克,0.013莫耳 4’-三氟甲基氰乙 醛替苯胺/10Q毫升乾燥四氫呋喃懸浮液,在室溫攪拌 30分鐘。然後以1.3Q毫升,0.0143莫耳環丙烷羰氮滴入 處理此納鹽之濃稠懸浮液歴10分鐘,在室溫攪拌16小時 。加入1毫升水,攪拌混合物10分鐘,以2 Ν氫氛酸進行 酸化,以醋酸乙酯萃取。以硫酸鎂乾燥有機萃取液,減 壓蒸發。以15毫升二氣甲烷溫熱固態殘餘物,以二乙_ 稀釋,得2 . 7 2克(産率7 0 % )檫題化合物,為無色結晶, 熔點 2 1 2 - 3 °C (乙醇)。 (請先閱讀背而之注意事項再艰寫本頁) f 裝· 經濟部屮央標準而Α工消价合作社印3i 同 法 可製 得 下 列 化 合 物 例 2 1-( 3 - 氛 苯 胺 基 甲 m )- 2 - 琛 丙 基 -2 -氧 丙 腈 例 3 1-( 4 - «tef TO 甲 苯 胺 基 甲 m )- 2 - 琛 丁 基- 2 - 氣 丙 m ; M. 4 1-( 4 - 二 氣 甲 苯 胺 基 甲 m )- 2 - 琛 戊 基- 2 - 丙 腈; 例 5 1-( 4 - 氟 苯 胺 基 甲 m )- 2 - 環 丙 基 -2 -氣 丙 腈 例 6 1-( 4 - 氮 苯 胺 基 甲 m )- 2 - 琛 丙 基 -2 丙 腈 例 7 1-( 4 - 溴 苯 胺 基 甲 m )- 2 - 琛 丙 基 -2 -氣 丙 腈 例 8 1-( 4 - 三 氟 甲 氣 苯 胺 基 甲 m )- 2 - 琿 丙基- 2 - 氣 丙膪 例 9 1 -( 4 - 硝 基 苯 胺 基 甲 m )- 2 - 環 丙 基 -2 - 氣 丙 硝 t 例 10 1 -( 3 , 4 - 二 氮 苯 胺 基 甲 m )- 2 - m 丙 基- 2 - 氧 丙 m ; 例 11 1 -( 4 - 碘 苯 胺 基 甲 m )- 2 - 琿 丙 基 _ 2 -氣 丙 m 例 8 1 -( 4 - 碘 苯 胺 基 甲 m )- 2 - m 丙 m -2 -氣 丙 Sri ; 步驟A: 4'-碘氰乙醯替苯胺 訂_ 線· 本紙5it尺度边用中B國家糅準(CNS)TM規格(210X29/公没)Λ (i Π fi 丄: R „II) Ministry of Economic Affairs 屮 楉 渉 准 工 消 " Cooperative Society Seal 31 (where R2, R3, iU, R5, 1 ^ 6 and 117 are as mentioned above, which are novel industrial products, It can be used as an intermediate for the production of compound I. Preferably compound (II), where R 3, R 6 and ϋ 7 are each a hydrogen atom: I pseudomethyl; and Rs is as described above but not a nitrogen atom or Methyl group. The following is a non-limiting example of the scope of the present invention: Window example 1 1- (4-trifluorotoluylaminomethyl) -2-propan-2-propionitrile; Step A: 4-Trifluoromethyl nitroacetanilide is not cooled, at 8.6 g, 1.01 mole cyanoethyl truncated aniline and 13.5 ml, 0.1 mole 4- (trifluoromethyl) aniline / 100 * L dry four To the argon furan solution was mixed with 16.4 ml, 0.1G5 of diisopropyl nitrated diimine and pressed for 10 minutes. When added, the temperature of the solution increased from 20 ° to 60 ° C. The mixture was stirred at room temperature 16 After filtration, the filtrate was evaporated to dryness to obtain a solid residue. It was suspended in 100 liters of ethyl alcohol, stirred at room temperature for 1 hour, with 50 * liter of ethyl alcohol, 2 X 1 0 0 1 liter of diazomethane and 2 X 1000 ml of hexane Wash. Dry at room temperature for 3 hours at 60 ° C to obtain 18.8 5 g of diseased substance (yield 83%), melting point 195-6 ° C (colorless crystals). 10- This paper 5 good-scale use in medium SH Family Standard (CNS) fM specification (210x297 mm) (Please read the back to the first note ^ Item # Item write this page) Μ Λ Π 6 5. Description of the invention (9) Step B: 1-(4-three Fluorotoluylaminomethyl) -2-cyclopropyl-2-gas propionitrile was treated with 80% hydrogenated sodium oil dispersion (Q. 8 8g, 0.0 2 8 6 mol) under dry nitrogen 3 · 0g, 0.013mol 4'-trifluoromethyl cyanoacetaldehyde aniline / 10Qml dry tetrahydrofuran suspension, stirred at room temperature for 30 minutes. Then with 1.3Qml, 0.0143mol earrings propane carbonyl nitrogen drop treatment The thick suspension of sodium salt was stirred for 10 minutes at room temperature for 16 hours. 1 ml of water was added and the mixture was stirred for 10 minutes, acidified with 2 N hydrogen acid and extracted with ethyl acetate. The organic extract was dried over magnesium sulfate , Evaporate under reduced pressure. Warm the solid residue with 15 ml of difluoromethane and dilute with diethyl ether to give 2.7 g (70% yield) of the title compound as colorless crystals, melting point 2 1 2-3 ° C (ethanol ). (Please read the precautions before writing this page) f. The standard of the Ministry of Economic Affairs and the printing of 3G by A Gongxiao Cooperative Co., Ltd. can be prepared by the same method. Example 2 1- (3-Amino aniline group A m)-2 -Chen propyl-2 -oxypropionitrile Example 3 1- (4-«tef TO toluylmethyl m)-2-C-butyl butyl-2-gas propane m; M. 4 1- ( 4-Difluorotoluidinemethyl m)-2 -Chenpentyl-2 -propionitrile; Example 5 1- (4- Fluoroanilidene m)-2 -Cyclopropyl-2 -Gasopropionitrile Example 6 1 -(4-azinopropylmethyl m)-2 -propenyl-2 propionitrile example 7 1- (4 -bromoanilinyl m)-2 -chenpropyl-2 -gas propionitrile example 8 1- ( 4-Trifluorotolylaniline m)-2 -Hunpropyl-2 -pyrrolidine Example 9 1-(4 -Nitroanilinem)-2 -cyclopropyl-2 -pyrrolid Example 10 1-(3, 4 -diazoaniline m)-2-m propyl-2 -oxypropyl m; Example 11 1-(4-iodoaniline m)-2 -hypromyl_ 2 -Gasopropanol Example 8 1-(4-iodoanilide m)-2-m Propane m -2 -Propylene Sri; Step A: 4'-iodocyanoacetanilide _ line · 5B scale side paper of this paper is used in China National Standard (CNS) TM specification (210X29 / public)

Λ fi H G k.024^? 五、發明説明(θ) 在室溫水浴中,於35. 25克,0.17莫耳五氛化磷/ 250 毫升乾燥二氯甲烷懸浮液中,攛拌加入14. 41克,0.17 莫耳氰醋酸,歴2分鐘。加熱回流0.5小時,然後以氮 氣沖洗2分鐘。加入24.75克,0.113莫耳4 -碘苯胺,回 流攪拌混合物2小時,冷卻,倒入30Q毫升水中。擻烈 攪拌混合物1小時,過濾,使固態殘留物和磺酸氫納水 ▼ 溶液攪拌,過濾,依序以水及乙酵洗固龌,g6 0°C真空乾 燥。得29. 51克(91 %産率)4'-碘氛乙醒替苯胺, 熔點 2 1 6 - 8 °C。 步驟B: 1-(4-碘苯胺基甲醯)-2-環丙基-2-氣丙腈 仿例1步驟B,由前所得4’-碘氣乙醯替苯胺可得標題 化合物。 例1 2 1-(4-溴-3-甲苯胺基甲醛)-2-環丙基-2-氣丙晴; 步费S A : 4-溴-3-甲基氰乙醯替苯胺 在40°C攪拌0.457克,5. 37莫耳氰醋酸/ 30毫升乾燥 二氣甲烷溶液及1 . 〇 〇克,5 . 3 7其耳4 -溴-3 -甲苯胺,加 入1.135克,5. 5毫莫耳二環己基磺化二亞胺/ 5毫升二 氮甲烷歴2分鐘。添加時,溶液溫度不超過4Q°C^闱拌 反應1小時後,终於冷卻至室溫。冷卻時.結晶析出二 琛己P症物,並過猫。以二氮甲烷洗固體三次。蒸發濾 液至乾固,将固體殘餘物。圓柱層析固醱殘餘物,以逐 漸提高醏酸乙酯百分率之二氮甲烷洗滌,産率87 %。 步驟B : 1 - ( 4 -溴-3 -甲苯胺基甲醯)-2 -環丙基-2 -氣丙腈 -1 2 - 本紙尺度边用中as家详準(CNS)T4規格(210X29V公釐) (請先閲访背而之注意事項洱褀窍木页) 裝. 訂 經濟部屮央榣準而Μ工消代合作社印1i u 024^ Λ fi Π β 經濟部屮央#準·-工消听合作社印3i 五、發明説明(") 在乾燥氮氣下,不斷攪拌,以催化量的咪唑處理300 毫克,1.19毫莫耳(1當量)4 -溴-3-甲醯胺加合物/12 毫升乾燥四氫呋喃溶液。加入626毫克,2.2當量,2.61 毫莫耳氫化鈉之8D%油分散液,在室溫攪拌反應15分鐘 t 。在所得納鹽中滴入0.0843毫升,124毫克,1.85毫莫 耳(1當量)環丙烷羰氣歴3分鐘,在室溫攪拌2小時β 將反應混合物倒入最少量的放水中,以1Μ氫氱酸酸化至 ΡΗ 2,攪拌混合物約1分鐘,直到所有固體沈澱析出。 過濾固體,以水洗,然後以最少量乙醚洗,得標題化合 物,為乳白色結晶(産率8 3 % )。 例1 3 1-(3,4-甲撐二氣甲苯胺基甲醯)-2-環丙基-2-氣 丙腈 步驟A: 3,4 -甲撐二氣氰乙醯替苯胺 在室溫攪拌685毫克,3. 29毫契耳,(1. 5當量)五氯化 磷/10毫升乾燥二氣甲烷懸浮液,加入279毫克,3.29 毫莫耳(1.5當量)氰醋酸,歷1分鐘。加熱回流混合物 3 0分鐘,然後以氮氣沖洗2分鐘。加入3 0 0毫克,2 . 1 9 毫Μ耳3 , 4 -甲撐二氣苯胺,加熱回流1 0分鐘,然後冷卻 在室溫,倒入1 0毫升水中。激烈攪拌混合物3 0分鐘,過 濾固態殘餘物,侬序以水洗最少遣的乙酤及醋酸乙酷洗 ,鹿量 3 3 0 « 兖(4 9 % )。 步驟Β : 1 - ( 3 , 4 -甲撐二氣苯胺胺基甲醯)-2 -環丙挂-2 - 氧丙硝 13 本紙張尺度边用中a國家糅準(CNS)ΤΊ規格(2]0X297公没) (請先閲請背而之注意事碩再碣寫本頁) 裝· 訂_ 線· r Λ fi 15 (i 五、發明説明(|>) 仿例1步驟前面所得3, 4,-甲撐二氣氰乙醯替苯胺 ,可得標題化合物。 仿例1 3 ,可得下列化合物: 例14 : 2-氣-3-環丙基-3-氣-N -甲基- N- (4-氯苯)丙醛胺 例15 : 1-(4 -氯-2-甲苯胺基甲 )-2 -環丙基-2-氧丙腈 經.16 : 1-(3,4-二氟苯胺基甲醛)-2-環丙基-2-氣丙腈 例17 : 1-(4-甲氣苯胺基甲醯)-2-環丙基-2-氣丙腈 倒1 8 : 1-(4-氛苯胺基甲醛)-2-環丙基-2-氣丙腈 例19 : 1-(3,5-二氛苯胺基甲醒)-2-環丙基-2-氧丙腈 例20 : 1-(4-氣-3-甲基苯胺基甲_ )-2-環丙基-2-氣丙 腈 例21 : 1-(3 -三氟甲苯胺基甲醛)-2 -琿丙基-2-氣丙腈 例22 : 1-(4 -甲苯胺基甲醯)-2 -環丙基-2-氣丙腈 例23 : 1-(4 -氯-3-三氟甲苯胺基甲醛)-2 -環丙基-2-氣 丙睛 例24 : 1-(苯胺基甲IS )-2-琿丙基-2-氣丙腈 例25 : 1-(3 -甲基-4-三氟甲苯胺基甲_ )-2 -環丙基- 2- 氣丙拜寿 經洧部屮央桴準·工消"合作社印3i (請先閱讀背而之注意事項#塡寫木頁) 例—26 : 1- (4-碘-3-甲苯胺基甲K ) - 2 -琛丙基-2 -氣丙腈 1 - ( 4 -概-3 -甲苯胺基甲K ) - 2 -環丙軚-2 -氣丙Μ 例28 : 卜(4 -氛-3 -甲苯胺轵甲Κ ) - 2 -環丙钱-2 -氣丙Μ _卜〔4 - ( 2 , 2 , 2 -三弒乙氣)苯伎基屮酡]-2 -琛丙 基-2 -氣丙請 14 本紙张尺度边用中國Η家標毕(CNS)<fM規tt(2]0x297公放) 經濟部屮央標準而β工消贽合作社印rt'14 Λ fi _ Π 6_ 五、發明説明(β ) 例30 : 1-(3-甲基-4-硝基苯胺基甲醛)-2-環丙基-2-氣 丙腈 例31 : 1-(4-第三丁基苯胺基甲醯)-2-環丙基-2-氣丙腈 例32 : 1-(3-甲基苯胺基甲酵)-2-環丙基-2-氣丙腈 例33 : 1-(4-三氟甲硫苯胺基甲醯)-2-環丙基-2-氣丙腈 例34 : 1-(4-甲氣羰苯胺基甲醒)-2-琛丙基-2-氣丙腈 例35 : 1-(4-乙醯苯胺基甲篚)-2-環丙基-2-氣丙腈 例3 6」——1-(3,4-二甲氧苯胺基甲_ )-2-環丙基-2-氣丙腈 例37 ·· 1-(3-氛-4-甲苯胺基甲醛)-2-環丙基-2-氣丙腈 例3 8 : 卜(4-甲硫苯胺基甲醛)-2-琿丙基-2-氣丙腈 Μ 39 = 1-(3-乙基-4-硝基苯胺基甲醛)-2-環丙基-2-氣 丙腈 例40 : 2-氰-3-環丙基-3-氣-N-甲基- N-(3-甲基-4-三 氟甲苯)丙S胺 例41 : 卜(4 -溴二氟甲氣-3-甲苯胺基甲醯)-2 -環丙基 -2-氣丙腈 例42 : 2-氣-3-環丙基-3-氣-N-甲基- N- (4-氰苯)丙醛胺 例43 : 2-氰-3-環丙基-3-氣甲基- N-(4-硝基苯)丙 醛胺 Μ 44 1 - ( 3 -甲基-4 -三概甲氣苯胺菡甲醯)-2 -環丙基 -2 -氣丙腈 例45 : 1-(3 -甲基-4-五氟乙苯胺基屮醯)-2 -環丙基-2 -氣丙膀 本紙51c尺度边用中01困家樣準(CNS)<fM規格(210X29/公甘) (請先閲請背而之注意事項再艰寫木頁) 裝. 線- 經浒部屮央標準·>!·;Α工消资合作杜印3i Λ 6 Π 6 五、發明説明(<4) 例4fi : 2-氣-3-環丙基-3-氣-N-甲基- N- (4 -溴-3-甲苯 )丙醯胺 例47 : 1-(4 -氣-3-乙苯胺基甲醛)-2 -環丙基-2-氣丙腈 例48 : 1-(4-羧苯胺基甲醛)-2-環丙基-2-氣丙腈 例41所用:>1-(淖二蕴甲氮)-2 -甲甚-4-胺荣夕製法如下: 在30厘米3乙醇中溶解0.92克納,加入6克2 -甲基-4 -硝基酚。減壓蒸發除去溶劑,然後加入苯。將所得納 鹽加入含24厘米3二甲基甲醛胺,30厘米3二溴二氟甲 烷及做為觸媒之少量乙硫醇之混合物中。在70 °C加熱混 合物1 Q小時,然後倒入冰中,以醋酸乙酯萃取。依序以 0.5M氫氣化鈉水溶液及水洗,乾燥及減壓除去溶劑《在 矽膠以醋酸乙酷/己烷4:96洗提,將所得3.35克 1-(溴 二氟甲氣)-2 -甲基-4-胺苯在把/活性炭之存在下氳化, 得所欲産物。 例44所用夕2 -申甚-4 -胺-1-三复甲簋采開始物皙Μ 法如下: 在175°C密封的燒瓶中,加熱0.3克1-(溴二氟甲氣)-2 -甲基-4-硝基苯,0.12Q克三氣化銻及Q.Q2克做為觸媒 之五氮化銻4小時。以水稀釋混合物,乾燥,減壓蒸發 i容劑,使所得〇 . 1 3克2 -甲基-4 -硝甚-1 -三氟甲氣苯在把 /活性炭存在下氪化,得所欲鹿物。 例4 5所用?-甲某-4 -防-〗-7Γ斑7,呆開始物皙靱法如 下: 本紙51k尺度边用中a國家«毕ΚΝ5)>ίΜ«ΙίΜ2Κ1χ297公让) (請先閲筇背而之注意事項#碼窍木頁) 裝· A fi _HG_Λ fi HG k.024 ^? V. Description of the invention (θ) In a water bath at room temperature, in 35.25 g, 0.17 mol phosphorus pentachloride / 250 ml dry dichloromethane suspension, stir and add 14. 41 grams, 0.17 mole cyanoacetic acid, 2 minutes. Heat to reflux for 0.5 hours, then flush with nitrogen for 2 minutes. 24.75 g, 0.113 mol 4-iodoaniline was added, the mixture was stirred under reflux for 2 hours, cooled, and poured into 30Q ml of water. Stir the mixture for 1 hour and filter to make the solid residue and sodium sulfonate solution ▼ Stir the solution, filter, wash the solid with water and ethyl yeast in order, and dry in vacuum at 60 ° C. This gave 29.51 g (91% yield) of 4'-iodoacetamide, melting point 2 1 6-8 ° C. Step B: 1- (4-iodoanilinylcarboxamide) -2-cyclopropyl-2-fluoropropionitrile In Example 1, Step B, the title compound can be obtained from the previously obtained 4'-iodofluoroacetanilide. Example 1 2 1- (4-Bromo-3-tolylcarbaldehyde) -2-cyclopropyl-2-propanal; Step fee SA: 4-bromo-3-methylcyanoacetanilide at 40 ° C was stirred 0.457 g, 5. 37 mol cyanoacetic acid / 30 ml dry methane solution and 1. 00 g, 5. 3 7 er 4-bromo-3-toluidine, added 1.135 g, 5.5 milligrams Mole dicyclohexyl sulfonated diimine / 5 ml diazomethane for 2 minutes. At the time of addition, the temperature of the solution did not exceed 4Q ° C. After stirring for 1 hour, the solution was finally cooled to room temperature. When cooling, the crystals precipitated the two Phenomenon and passed the cat. Wash the solid three times with diazomethane. Evaporate the filtrate to dryness and remove the solid residue. Cylindrical chromatography solidified the residue, washed with diazomethane gradually increasing the percentage of ethyl acetate, and the yield was 87%. Step B: 1-(4 -Bromo-3 -toluylmethylformamide)-2 -cyclopropyl-2 -propionitrile-1 2-This paper is used in the national standard (CNS) T4 specification (210X29V Mm) (please read the precautions in advance), install it. Ordered by the Ministry of Economic Affairs, Biyang and Mongong Daidai Cooperative Society 1i u 024 ^ Λ fi Π β Economic Ministry, Biyang # quasi · -Gongxiaoting Cooperative Printed 3i V. Description of the invention (") Under dry nitrogen, stirring continuously, with a catalytic amount of imidazole to treat 300 mg, 1.19 mmol (1 equivalent) 4-bromo-3-carboxamide plus Compound / 12 ml of dry tetrahydrofuran solution. Add 626 mg, 2.2 equivalents, 2.61 mmol of sodium hydride in 8D% oil dispersion, and stir at room temperature for 15 minutes t. Add 0.0843 ml, 124 mg, 1.85 millimoles (1 equivalent) of cyclopropane carbonyl gas to the resulting sodium salt for 3 minutes, stir at room temperature for 2 hours. Β Pour the reaction mixture into a minimum amount of water, with 1M hydrogen The acid was acidified to PH 2 and the mixture was stirred for about 1 minute until all solid precipitated. The solid was filtered, washed with water, and then washed with a minimum amount of ether to obtain the title compound as milky white crystals (yield: 83%). Example 1 3 1- (3,4-Methylenedigas tolylaminomethyl) -2-cyclopropyl-2-gaspropionitrile Step A: 3,4-Methylenedigas cyanoacetanilide in the room Stirring at a temperature of 685 mg, 3.29 mmol, (1.5 eq) phosphorus pentachloride / 10 ml dry methane suspension, adding 279 mg, 3.29 mmol (1.5 eq) cyanoacetic acid for 1 min . The mixture was heated to reflux for 30 minutes and then flushed with nitrogen for 2 minutes. 300 mg, 2.19 mM 3,4-methylenedioxyaniline was added, heated to reflux for 10 minutes, then cooled at room temperature and poured into 10 ml of water. Stir the mixture vigorously for 30 minutes, filter the solid residue, wash the ethyl acetate and ethyl acetate with water at least in order, and the amount of deer is 3 3 0 «Yan (49%). Step Β: 1-(3, 4 -Methylenedigas aniline aminoformamide)-2 -cyclopropanone-2-oxypropyl nitrate 13 This paper is used in the national standard (CNS) ΤΊ specifications (2 ] 0X297 Gongmei) (please read the note beforehand and write this page again) Install · Order _ Line · r Λ fi 15 (i 5. Description of the invention (| >) Example 1 Step 3 , 4, -Methylenedichlorocyanoacetanilide, to obtain the title compound. Example 1 3, the following compounds can be obtained: Example 14: 2-gas-3-cyclopropyl-3-gas-N-methyl -N- (4-chlorobenzene) propionaldehyde amine Example 15: 1- (4-chloro-2-tolylmethyl) -2-cyclopropyl-2-oxopropionitrile. 16: 1- (3, 4-Difluoroanilinocarbaldehyde) -2-cyclopropyl-2-pyriopropionitrile Example 17: 1- (4-Methoxyanilinocarbamide) -2-cyclopropyl-2-pyropropionitrile poured 1 8 : 1- (4-Aminoanilinocarbaldehyde) -2-cyclopropyl-2-pyropropionitrile Example 19: 1- (3,5-Dihydroanilinocarbamide) -2-cyclopropyl-2-oxo Propionitrile Example 20: 1- (4-Gas-3-methylanilinomethyl _)-2-cyclopropyl-2-Gasopropionitrile Example 21: 1- (3-Trifluorotoluidine formaldehyde) -2 -Hengpropyl-2-gas propionitrile Example 22: 1- (4-tolylaminoformamide) -2-cyclopropyl-2-gas propionitrile Example 23: 1- (4-chloro-3-trifluoro Toluyl formaldehyde) 2-cyclopropyl-2-pyrrolidone Example 24: 1- (anilinomethyl IS) -2-propan-2-yl propionitrile Example 25: 1- (3-methyl -4-Trifluorotoluylmethyl _) -2 -cyclopropyl-2- 2-propargyl sapphire by the Ministry of Agriculture, the Ministry of Industry and Industry " Cooperative Society Printed 3i (please read the back-end precautions # 塡 写Wooden sheet) Example—26: 1- (4-iodo-3-toluidine methyl K)-2-2-methylpropyl-2-propionitrile 1-(4-overview-3-toluyl methyl K)- 2-Cyclopropylpyridine-2-gas propylene M Example 28: Bu (4-atmosphere-3-toluidine ketamine K)-2-cyclopropyl money-2 gas propane M _ Bu [4-(2, 2, 2 -Sanyiyiqi) Benji-Jiyi] -2 -Chenpropyl-2 -Cypropropyl 14 This paper is printed on the Chinese standard (CNS) < fM regulations tt (2) 0x297 ) The standard of the Ministry of Economic Affairs and printed by the β Gong Xiao Zhi Cooperative Society rt'14 Λ fi _ Π 6_ V. Description of the invention (β) Example 30: 1- (3-methyl-4-nitroaniline formaldehyde) -2- Cyclopropyl-2-gas propionitrile Example 31: 1- (4-third butyl anilinoformamide) -2-cyclopropyl-2-gas propionitrile Example 32: 1- (3-methylanilino group Alpha-enzyme) -2-cyclopropyl-2-fluoropropionitrile Example 33: 1- (4-trifluoromethylthioanilinoformamide) -2-cyclopropyl-2-fluoropropane Example 34: 1- (4-Methoxycarbonylanilinomethyl) -2-propen-2-pyropropionitrile Example 35: 1- (4-Acetylanilinomethan) -2-cyclopropyl- 2-Gasopropionitrile Example 3 6 "-1- (3,4-Dimethoxyanilinyl methyl)) -2-cyclopropyl-2-Gasopropionitrile Example 37 1- (3-Atmosphere-4 -Tolylamino formaldehyde) -2-cyclopropyl-2-pyriopropionitrile Example 3 8: Bu (4-methylthioanilide formaldehyde) -2-hypromyl-2-pyropropionitrile M 39 = 1- ( 3-Ethyl-4-nitroanilinocarbaldehyde) -2-cyclopropyl-2-gas propionitrile Example 40: 2-cyano-3-cyclopropyl-3-gas-N-methyl-N- ( 3-Methyl-4-trifluorotoluene) propan Samine Example 41: Bu (4-bromodifluoromethane-3-toluylmethylformamide) -2-cyclopropyl-2-gas propionitrile Example 42: 2-Gas-3-cyclopropyl-3-Gas-N-methyl-N- (4-cyanobenzene) propanalamine Example 43: 2-cyano-3-cyclopropyl-3-Gasomethyl-N -(4-Nitrobenzene) propanal amine M 44 1-(3 -methyl-4 -trimethylmethanil aniline hexamidine) -2 -cyclopropyl-2 -gas propionitrile Example 45: 1- ( 3-Methyl-4-pentafluoroethylanilinyl-pyridine) -2-cyclopropyl-2-gas propylene on paper 51c scale side use medium 01 sleepy home standard (CNS) < fM specification (210X29 / grand ) (Please read the back-to-back precautions first and then write the wooden page hard) 装. 线- Standards of the Margin Department · >!·; A Industrial and Consumer Cooperation Du Yin 3i Λ 6 Π 6 V. Description of the invention (< 4) Example 4fi: 2-Gas-3-cyclopropyl-3-Gas- N-methyl-N- (4-bromo-3-toluene) propionamide Example 47: 1- (4-gas-3-ethylanilinyl formaldehyde) 2-cyclopropyl-2-gas propionitrile Example 48 : 1- (4-Carboxanilinyl formaldehyde) -2-cyclopropyl-2-gas propionitrile Example 41 used: > 1- (Naobiyun methyl nitrogen) -2-methan-4-amine Rongxi production method As follows: Dissolve 0.92 g of sodium in 30 cm 3 of ethanol and add 6 g of 2-methyl-4-nitrophenol. The solvent was evaporated under reduced pressure, and then benzene was added. The resulting sodium salt was added to a mixture containing 24 cm 3 of dimethyl formaldehyde amine, 30 cm 3 of dibromodifluoromethane and a small amount of ethanethiol as a catalyst. The mixture was heated at 70 ° C for 1 Q hours, then poured into ice and extracted with ethyl acetate. Sequentially wash with 0.5M aqueous sodium hydroxide solution and water, dry and remove the solvent under reduced pressure "elute with ethyl acetate / hexane 4:96 on the silica gel, extract 3.35 g of 1- (bromodifluoromethane) -2- Methyl-4-aminobenzene is converted in the presence of activated carbon to obtain the desired product. Example 44 used the 2-Shenshi-4-amine-1-trimethoprene starting material method as follows: In a sealed flask at 175 ° C, heat 0.3g of 1- (bromodifluoromethane) -2 -Methyl-4-nitrobenzene, 0.12Q grams of antimony tri-gasified and Q.Q2 grams of antimony pentanitride as catalyst for 4 hours. The mixture was diluted with water, dried, and the solvent was evaporated under reduced pressure, so that the resulting 0.13 g of 2-methyl-4-nitrogen-1-trifluoromethane was kryptonized in the presence of activated carbon. Deer. Example 4 5 used? -Jiamou-4 -anti-〗-7Γ plaque 7, the beginning method is as follows: The 51k scale of the paper is used in the middle of the country a «Bi ΚΝ5) > ίΜ« ΙίΜ2Κ1χ297 public concession) (please read the book first Matters needing attention # code qiaomu page) installed · A fi _HG_

五、發明説明(I 在氬氣下,於密封容器中之ίο厘米3二甲基甲S胺中 混合2.36克 1-碘-2-甲基-4-硝基苯及2. 2克銅粉(預先 依序以水及丙酮洗,減壓乾燥過,參閲"Crg, Synthesis Coll."卷II, 1948年,445頁)。冷卻混合物至- 60°C, 加入11.5克五氟乙基化碘)。在160°C及3.5巴壓力攙拌 1 6小時,接著在冰中冷卻,恢復至室溫。將混合物倒入 冰中,以醋酸乙酯萃取,以水洗,乾燥,減E蒸發溶劑 。在二氣化矽層析以含2-3%二氣甲烷之戊烷洗提,使 所得1.5克 2 -甲基-4-硝基-1-五氟乙苯在粑存在下氫化 ,可得所·欲産物。 光譜數據,産率,熔點及分析數據記錄於表I中。 例 49 : 由下列组成物製備錠片(1粒): 2 〇毫克例1化合物 130毫克賦形劑(包含乳糖,澱粉,滑石,硬脂酸鎂)。 例50 由下列組成物製備錠片U粒): 2 0毫克例2化合物 (請先閲筇背而之注总事項丹填寫本頁) 裝- 訂 線_ 0 酸 脂 硬 石 滑 粉0 糖 乳 含 包 /(\ 劑 形 賦 克 « ο 經濟部十央標準杓只工消作合作社印驭 本紙尺度边用中困Η家樣毕(CNS)TM規格(210x297公没) r;ifJ42 66 ΛΒ 經濟部屮央標準而只工消扑合作社印31V. Description of the invention (I Under argon, mix 2.36 g of 1-iodo-2-methyl-4-nitrobenzene and 2. 2 g of copper powder in a 3 cm dimethyl methyl Samine in a sealed container (Wash with water and acetone in advance and dry under reduced pressure, see " Crg, Synthesis Coll. &Quot; Volume II, 1948, page 445.) Cool the mixture to-60 ° C, add 11.5 g of pentafluoroethyl Iodide). Mix at 160 ° C and 3.5 bar pressure for 16 hours, then cool in ice and return to room temperature. The mixture was poured into ice, extracted with ethyl acetate, washed with water, dried, and evaporated to remove the solvent. It is eluted by chromane with 2-3% difluoromethane in digasification silica chromatography, and the resulting 1.5 grams of 2-methyl-4-nitro-1-pentafluoroethylbenzene is hydrogenated in the presence of 粑. What you want. Spectral data, yield, melting point and analytical data are recorded in Table I. Example 49: A tablet (1 tablet) is prepared from the following composition: 20 mg of the compound of Example 1 and 130 mg of excipient (containing lactose, starch, talc, magnesium stearate). Example 50 U tablets (tablets) were prepared from the following composition: 20 mg of the compound of Example 2 (please read the general notes first and fill in this page) to pack-line_ 0 acid hard rock smooth powder 0 sugar milk Contains the package / (\ dosage form fug «ο The Ministry of Economic Affairs Shiyang standard 杓 only work consumer cooperation cooperatives printed and printed on the paper standard side use Η home sample Bi (CNS) TM specifications (210x297 public) r; ifJ42 66 ΛΒ economy Ministry of the Central Standards and only work to eliminate the cooperative printed 31

(請先閲讀背而之注意事項#填寫本頁) 2 ο ίΜ 66 ΛΒ •/J °/J 1Γ 、立 10 .9 7.22(2'd) ; 2.15( l'm) 31( 2'旦;1.18( 2H、Ta) DMSO 丨 12.27(1H、S); 8.19{2H,dr7.79{2H、d); 2.20(lH、m) ;°.s(4H,m) CDC13 丨 15.61(1H,S) 3·66(1'Π0; 2.24-H CDC13 , 15·S1(1H,S) 3.22(lH,m); 1.85(8H SC13 - 15. S(1H,S) 7_06(2H、彐);2,15(1H SC13 丨 15.77(l's) 7.33(2H,d); 2 .14(1H SC13 - 15.76(1H、S) 7·38(2Η-);2·14(1Η CDC13 丨 15.71(1H,S) 7·26(2'3) ; 2.14(1H CDC13 — 15.76(1H,S) 7.76(l's) ; 7 .64(4H、S); - 7.72(1H、S) ; 7 .64-'s); m) 7.61(1H,S) ; 7.42(2'm); m);1.32 (2H,m);1.16(2H,m) 7.s(lH、s);7.44(s、d); m) ;l-l(2H、m) ;1.16(2H,m) 7,62(1H,S); 7.48(2H,d); m) ; 1.32 (2Η,τα) ; 1.25( 2'm) 7-67(2Hi;7..53(lH,s); 3) ;1.34(2'm) ;l-6(2'm) 7,73(1H,S); 7.53{2H,d); CDC13 丨 l-64(l'sr7、77(lH、s); 7.64(4H,S); 2 16(1Η,Π0; 1 37(2H,Tnrl 18(2'm) SC13 i 157°(1H,S); 7.65(1H,S); 7.63(l's); 7.25(3'm) ;2·16(1Η,Ιη) ; 1*34 (2H,m) ; 1.18( 2-Tn) 芄齡氺^$ (請先閱請背而之注意事項洱蜞寫本頁) 绵- cl^nllowiiwFS 282」26 C13H11N202C1 262.69 C15H13N202F3 310.28 C16H15N203F3 324.31 C13H11N202F 246.24 C13H11Z2°2C1 262.69 C13HllN202Br 307·15 C13H11N202I ·1Λ C14H112203F3 312.2^ C13H11N304 273·25 經濟部t央梂準/0只工消"合作社印驭 57. 1'4.07 15· 38 53.85 3_55 8.97 18.25 44.s 3,h3 7.山一 35.83 59 _ 4办 f 22 10.66 13 · 49 59.35-^. 30 10.67 13. 51 so·®·**3.61 26.02 63_ 41 4.50 11.38 13.00 26 办 17 办 66s sss 58 3 03 44-^ 22 10 2ot1° 224° 28 叻 56,76 3 -7厶 ^ 56,81 3.-^1°山 H% - 02 18.37 02 18·43 64 17.58 63 17.63 46 19*25 45 19.25 s M3. 49 65 13.52 x% - 規 4 甲 VI/ Nsi(c 準 家 國 a -中 用 边 度 尺 本(Please read the back-end notes first #fill this page) 2 ο ίΜ 66 ΛΒ • / J ° / J 1Γ, Li 10.9 7.22 (2'd); 2.15 (l'm) 31 (2 'den; 1.18 (2H, Ta) DMSO 丨 12.27 (1H, S); 8.19 {2H, dr7.79 {2H, d); 2.20 (lH, m); ° .s (4H, m) CDC13 丨 15.61 (1H, S ) 3 · 66 (1'Π0; 2.24-H CDC13, 15 · S1 (1H, S) 3.22 (lH, m); 1.85 (8H SC13-15. S (1H, S) 7_06 (2H, wa); 2 , 15 (1H SC13 丨 15.77 (l's) 7.33 (2H, d); 2.14 (1H SC13-15.76 (1H, S) 7.38 (2Η-); 2.14 (1Η CDC13 丨 15.71 (1H, S ) 7.26 (2'3); 2.14 (1H CDC13 — 15.76 (1H, S) 7.76 (l's); 7.64 (4H, S);-7.72 (1H, S); 7.64-'s) ; M) 7.61 (1H, S); 7.42 (2'm); m); 1.32 (2H, m); 1.16 (2H, m) 7.s (lH, s); 7.44 (s, d); m ); Ll (2H, m); 1.16 (2H, m) 7,62 (1H, S); 7.48 (2H, d); m); 1.32 (2Η, τα); 1.25 (2'm) 7-67 (2Hi; 7..53 (lH, s); 3); 1.34 (2'm); l-6 (2'm) 7,73 (1H, S); 7.53 {2H, d); CDC13 丨 l -64 (l'sr7,77 (lH, s); 7.64 (4H, S); 2 16 (1Η, Π0; 1 37 (2H, Tnrl 18 (2'm) SC13 i 157 ° (1H, S); 7.65 (1H, S); 7.63 (l's); 7.25 (3'm); 2.16 (1Η, η); 1 * 34 (2H, m); 1.18 (2-Tn) 芄 昄 氺 ^ $ (please read the notes on the back of this page to write this page) Mian-cl ^ nllowiiwFS 282 ″ 26 C13H11N202C1 262.69 C15H13N202F3 310.28 C16H15N203F3 324.31 C13H11N202F 246.24 C13H11Z2 ° 2C1 262.69 C13HllN202Br 307 · 15 C13H11N202I · 1Λ C14H112203F3 312.2 ^ C13H11N304 273 · 25 Ministry of Economic Affairs t Central Development Co., Ltd. 53. 18.25 44.s 3, h3 7. Yamaichi 35.83 59 _ 4 Office f 22 10.66 13 · 49 59.35- ^. 30 10.67 13. 51 so · ® ** 3.61 26.02 63_ 41 4.50 11.38 13.00 26 Office 17 Office 66s sss 58 3 03 44- ^ 22 10 2ot1 ° 224 ° 28 Lat 56,76 3 -7 厶 ^ 56,81 3 .- ^ 1 ° Mountain H%-02 18.37 02 18 · 43 64 17.58 63 17.63 46 19 * 25 45 19.25 s M3. 49 65 13.52 x%-Regulation 4 A VI / Nsi (c quasi-country country a-medium-sized ruler

\—/ -公 lJV 2 X 9\ — / -Male lJV 2 X 9

(請先閲讀背而之注*'?事項#*蜞哀本頁) 裝::訂::線 7 -" - 一 2 ο 6 6 ΛΠ 明 18 乳 n/J 1t19 立 20 1*7 15 13 12 11 令一 DMSO 丨 11.89(1H,S); 7.74 (4H,m); 2.2 P9 (4H,m) DMSO - 11.89(1H,S); 7.66(2H、S); 7.18(1H,S); 2 .19 (lH、m) ; 0 .s (4H、m) DMSO - ll.536{lH、s); B.04(lH,m); 7.52(lH,m); 7.45(lH、m); 2.l9(lH、m); 0.95(4H、m) DMSO - 10.97(1H,S); 7.54(2H、m); 7.39(153),. 2.34(3H,S) ;2.19(lH、m) ; l.s(4H,m) CDC13 - 15.89 (lH,sr7.44(1H、S);7.10(1H,3); 6 .7 8(2H,m) ; 5.99(2H,S);2 .10;1.26(4H、m) SC13 - 17.09(1H,S); 7.44(2H,d); 7.23(2H,dr 3 -34(3H,S) ; 2 .13(lH、m) ;1.24(2H,m) ;l.s(2H,m) DMSO - 10.807(1H,S); 7.72{lH、m); 7.35(lH、m); 7.27(lH,m) ; 2 .22 (353) ;2.19 (lH,mrl'o2 (4H,m) DMSO - 11.20(1H,S); 7.80(lH、m); 7.37(2H、m); 2.19(lH、mrl. 01(4H,m) >1 (請先閲請背而之注意事項洱填窍木頁) 線_ C14H11N302 253 .932 C13K10Z2C12 2VO7 · 132 C14H14hf202 242.2 C13H10C12Z2O2 2<x>7_ 一办 C14H13N202BI: 321. C14H12N22 272.266 C14H13N202C1 276 .72 C14H13N202C1 276.714 C13H10N202F2 264.23 經濟部屮央標準/(·;β工消1\''合作社印!«. 69.4 5-325 11.57 13, 21 52.55 3.3VOVDkLJ23.86 66,21 4 .37 16. 55 60.76 10.13 12.81 60.69 4-7,7 10.10 12.002 59 . s 3 .03110. s 14 ·3Β 60.77 f73 10.12 12.82 52 52 61 61 35 办 21 办 IS 厶 65 办 52.55 3 52,37 3(Please read the note to the back * '? 事 ## 虞 Sad page) Pack :: order :: line 7-"-1 2 ο 6 6 ΛΠ Ming 18 乳 n / J 1t19 立 20 1 * 7 15 13 12 11 Lingyi DMSO 丨 11.89 (1H, S); 7.74 (4H, m); 2.2 P9 (4H, m) DMSO-11.89 (1H, S); 7.66 (2H, S); 7.18 (1H, S) ; 2.19 (lH, m); 0.s (4H, m) DMSO-ll.536 (lH, s); B.04 (lH, m); 7.52 (lH, m); 7.45 (lH, m) ); 2.l9 (lH, m); 0.95 (4H, m) DMSO-10.97 (1H, S); 7.54 (2H, m); 7.39 (153), 2.34 (3H, S); 2.19 (lH, m) m); ls (4H, m) CDC13-15.89 (lH, sr7.44 (1H, S); 7.10 (1H, 3); 6.7 8 (2H, m); 5.99 (2H, S); 2. 10; 1.26 (4H, m) SC13-17.09 (1H, S); 7.44 (2H, d); 7.23 (2H, dr 3-34 (3H, S); 2.13 (lH, m); 1.24 (2H , m); ls (2H, m) DMSO-10.807 (1H, S); 7.72 {lH, m); 7.35 (lH, m); 7.27 (lH, m); 2.22 (353); 2.19 (lH , mrl'o2 (4H, m) DMSO-11.20 (1H, S); 7.80 (lH, m); 7.37 (2H, m); 2.19 (lH, mrl. 01 (4H, m) > 1 (Please first (Please read the notes on the back page) Line_ C14H11N302 253 .932 C13K10Z2C12 2VO7 · 132 C14H14hf202 242.2 C13H1 0C12Z2O2 2 < x > 7_ First Office C14H13N202BI: 321. C14H12N22 272.266 C14H13N202C1 276 .72 C14H13N202C1 276.714 C13H10N202F2 264.23 Ministry of Economic Affairs Standards / (·; β 工 消 1 \ '' Cooperatives 5. 21 52.55 3.3VOVDkLJ23.86 66,21 4 .37 16. 55 60.76 10.13 12.81 60.69 4-7,7 10.10 12.002 59. S 3 .03110. S 14 · 3Β 60.77 f73 10.12 12.82 52 52 61 61 35 Office 21 Office IS嶶 65 Office 52.55 3 52,37 3

310g 二3 23-86 λ.5 9.37 丨 000οο^ίοMfs 1000.65 24.10 s 10.2U3I 办 7 10.18 I C 抑ΚΛ·料f:衅養: ΧΛ» 格 規 4 f \J/ s CN 準 家 s β 中 用 边 度 尺 張 本310g II 3 23-86 λ.5 9.37 丨 000οο ^ ίοMfs 1000.65 24.10 s 10.2U3I Office 7 10.18 IC suppression ΚΛ · material f: provocative: ΧΛ »standard 4 f \ J / s CN quasi-home s β middle-use side Ruler Zhang Ben

Λ 公t97 2 X 2 ο -V4 6 6 ΛΠ n/J 明 ,Γ f 立 30Λ male t97 2 X 2 ο -V4 6 6 ΛΠ n / J Ming, Γ f Li 30

2VO 28 21 201 2U1 23 22 212VO 28 21 201 2U1 23 22 21

207 I 3280(NH), 2220(CN)、 1620、 1520, 1470, 1400, 1340, 13G5, 126P1220, 1080, 1020, 975,910、CO90,CO2Q, 755、685、655、620 117 I 3290(NH), 222G(CN), 1600、 1450、 1415, 1350, 1320, 1265, 124 5,119 5,1180、109 0,1065, ISO, 99 0,92 0,89 5,805,77 0,755,69 5 1B6-C0I 3395 (NH),2204 (CNr163,°1600、15B0, 1545, 1409、1346、 1310, 1156, 1110, 1097, 1037、1027,03800,27, 51 163-5 I 32B4(NH),2000ON),1623, 1599、1565' 1525, 1469, 1400, 1371、 1338, 1301, 1250, 123B, B82 140-2 一 3280(NH),2002ΟΝΓ 1620, 1573, 1560, 1540、1491、1341、 1204, 886 300 I 32Β0(ΖΚ), 21votns(CM) , 21 厶 5W(C2), 1630, 158CO, lcnull, ltnoo, 1410, 1332, 1309, 1254, 1230、 877, B21 3380(NHr2002oNr1621, 1602、1578, 1551, 1540, 1502, 1477, 135,°128°1220, 1150, 1071, 8S 22316 1 3300, 3120, 2VO30, 2220, 1630,Mtn.70 ~ 15U10~ 1500~M办υιο、M.120, 1380, 1350,1290, 1270, 1240, 1090, 1070, 1040 經漪部屮央梂準/-JA工消坨合作杜印轧 本紙張尺度通用中as孓榣準(CNS)«M規格(210x297公;a:) 37S(NH)、2035ON),1545、1520, 1495, 1460, 1400, 1310, 1260、 1240' 1170, 1130,1060, 1025 8-0 (請先閲讀背而之注意事項4·填寫本頁) 裝· ^024^ 五、發明説明( >丨) u> 〇 ro νο207 I 3280 (NH), 2220 (CN), 1620, 1520, 1470, 1400, 1340, 13G5, 126P1220, 1080, 1020, 975,910, CO90, CO2Q, 755, 685, 655, 620 117 I 3290 (NH), 222G (CN), 1600, 1450, 1415, 1350, 1320, 1265, 124 5,119 5,1180, 109 0,1065, ISO, 99 0,92 0,89 5,805,77 0,755,69 5 1B6-C0I 3395 (NH ), 2204 (CNr163, ° 1600, 15B0, 1545, 1409, 1346, 1310, 1156, 1110, 1097, 1037, 1027, 03800, 27, 51 163-5 I 32B4 (NH), 2000ON), 1623, 1599, 1565 '1525, 1469, 1400, 1371, 1338, 1301, 1250, 123B, B82 140-2-3280 (NH), 2002ΟΝΓ 1620, 1573, 1560, 1540, 1491, 1341, 1204, 886 300 I 32B0 (ZΚ) , 21votns (CM), 21 厶 5W (C2), 1630, 158CO, lcnull, ltnoo, 1410, 1332, 1309, 1254, 1230, 877, B21 3380 (NHr2002oNr1621, 1602, 1578, 1551, 1540, 1502, 1477, 135, ° 128 ° 1220, 1150, 1071, 8S 22316 1 3300, 3120, 2VO30, 2220, 1630, Mtn.70 ~ 15U10 ~ 1500 ~ M office, M.120, 1380, 1350, 1290, 1270, 1240, 1090, 1070, 1040 Jingyibeiyang central quasi / -JA 工 消 在 Cooperation Duinin rolled paper standard universal as 斓 榣 准 (CNS) «M Grid (210x297; a :) 37S (NH), 2035ON), 1545, 1520, 1495, 1460, 1400, 1310, 1260, 1240 '1170, 1130, 1060, 1025 8-0 (please read the notes first Matter 4 · Fill in this page) 装 · ^ 024 ^ V. Description of the invention (> 丨) u > 〇ro νο

CD ro NJ σ» Λ 6 W 6 Μ Νί N> fvj N> LT1 ·&· CJ f〇 μ-» DMSO - 12 . 01 (li's) ; 7.63 (3I'm) ; 2 .45 (3's); 2 . 21 (1'no ; 0.88-h,e SC13 I 15.87(1H、S); 7.52(2H,m); 7.42(2H,m); 7· 95 (2H,m) ; 4 . 34 (2H, q) ;2 ; 1 _ 33 (2H、Tn); DMSO - 11.65(l's); 8·02(1Η-);7.65(2Η,Γη); 2.53(3's); 2.17(lH、m);°95(4'm)CD ro NJ σ »Λ 6 W 6 Μ Νί N > fvj N > LT1 · & · CJ f〇μ-» DMSO-12.01 (li's); 7.63 (3I'm); 2.45 (3's); 2.21 (1'no; 0.88-h, e SC13 I 15.87 (1H, S); 7.52 (2H, m); 7.42 (2H, m); 7.95 (2H, m); 4.34 (2H , q); 2; 1_33 (2H, Tn); DMSO-11.65 (l's); 8.02 (1Η-); 7.65 (2Η, Γη); 2.53 (3's); 2.17 (lH, m); ° 95 (4'm)

CDS I 7· 00(1H rt η-» —tn CO OD ♦ U1 fsj ^ CD l·-» •V 工 U)、CDS I 7 · 00 (1H rt η- »—tn CO OD ♦ U1 fsj ^ CD l ·-» • V work U),

.49(1H,S) ; 7.24(2H、Tn); 1.33(2H、m) ;1,16(2H,£ DMSO 丨 11.49(l's); 8.23(lH,m); 7,81(lH,m); 7 . 67 (1'm) ; 2 . 22 (lxm) ; 1 .07 (4 H,m) DMSO , IP 68 (1H, s) ; 7.53 (2H、5 ; 7 ,36 (2Hi; 7.17 (1-旦;2 t 20 (l'm);l. 09 CDC13 * 15.S(1H,S); 7.59{2H,d);7.43{2H,d); 2-9 (3's) ; 2 · 15(1H, In) ; 1 ,35 (2'm) ; 1、19 (2H,m) CDC13 - 15.73(1H,S); 7.77(lH,d); 7,45(1H,S); 7.37(lH,dr7.06(lH,ddr2.43(3H,s); 2.14(l'm); 1.34(2'm); 1.17(2H,m) DMSO 1 11_ 7 . 36 (IHi U1 ro ‘ m re o、 > (/) n:、. 8 ·12 (1H, s) ; 7 . 68 (ΙΗ,τπ); mr0'9r4H,m) ^二荔 (請先閲讀背而之注"事項^:填寫木頁) 裝- 訂 C14H13N304 287,28 C14H13FN202 260.27 01^^13^3 02 267.29 C15X13F32203 326.28 C14H11N202F3 296.24 C14H14N2〇2 2-^2. 26 C14H1QC1F3N202 3:30-70 C13H12N2〇2 22B. 25 C15H13F3N202 31。· 28 C14H13IN202 368,18 經濟部屮央標準而只工消仰合作社印災 58.53 55· 22 67.^1 50.85 50.11 68 ,41 68.40 58.07 58. 00 45.67 56.76 5 · 3° 5.37 Γ22 f 30 3 ,56 5.03 办,^0 4.02 f 56 U> UJ U) u> • . t ! h-> 〇 CD 〇\ tn n; ^.49 (1H, S); 7.24 (2H, Tn); 1.33 (2H, m); 1,16 (2H, £ DMSO 丨 11.49 (l's); 8.23 (lH, m); 7,81 (lH, m ); 7.67 (1'm); 2.22 (lxm); 1.07 (4 H, m) DMSO, IP 68 (1H, s); 7.53 (2H, 5; 7, 36 (2Hi; 7.17 (1-dan; 2 t 20 (l'm); l. 09 CDC13 * 15.S (1H, S); 7.59 {2H, d); 7.43 {2H, d); 2-9 (3's); 2 · 15 (1H, In); 1,35 (2'm); 1, 19 (2H, m) CDC13-15.73 (1H, S); 7.77 (lH, d); 7,45 (1H, S); 7.37 (lH, dr7.06 (lH, ddr2.43 (3H, s); 2.14 (l'm); 1.34 (2'm); 1.17 (2H, m) DMSO 1 11_ 7.36 (IHi U1 ro ' m re o, > (/) n:,. 8 · 12 (1H, s); 7.68 (ΙΗ, τπ); mr0'9r4H, m) ^ Erli (please read the backnote first " Matter ^: fill in the wooden page) Binding-Order C14H13N304 287, 28 C14H13FN202 260.27 01 ^^ 13 ^ 3 02 267.29 C15X13F32203 326.28 C14H11N202F3 296.24 C14H14N2〇2 2- ^ 2. 26 C14H1QC1F3N202 3: 30-15C13H20 31. · 28 C14H13IN202 368,18 The Ministry of Economic Affairs standardizes and only works to support the cooperative's printing disaster 58.53 55 · 22 67. ^ 1 50.85 50.11 68, 41 68.40 58.07 58. 00 45.67 56.76 5 · 3 ° 5. 37 Γ22 f 30 3, 56 5.03 Office, ^ 0 4.02 f 56 U > UJ U) u > •. T! H- > 〇 CD 〇 \ tn n; ^

^•46 19.25 11.s 丨 B-7 10.72 ro3叻 10.73 12.27 I 12·32 I 9.03 18.37 ^-04 18.27 7.61 34_47 10 ,-^6^-° 15.72 丨 8.51° 14-3 I 本紙5良尺度边用中《 Η家«準(CNS)>fM規«5(210x29/公釐) Η% 耸蓄: ^0.. Ν% X%^ • 46 19.25 11.s 丨 B-7 10.72 ro3 lat 10.73 12.27 I 12 · 32 I 9.03 18.37 ^ -04 18.27 7.61 34_47 10,-^ 6 ^-° 15.72 丨 8.51 ° 14-3 I paper 5 good-size edges In use "Η home« quasi (CNS)> fM regulations «5 (210x29 / mm) Η% towering storage: ^ 0 .. Ν% X%

CH3 Η Η Η Η χ Η ΗCH3 Η Η Η Η χ Η Η

XX

A A A A A A 人 A A A 108,5-110 179丨81 ;Ml-2 12Ϊ 16Ϊ 158—60 188-vd 1-05101 10Ϊ ;Ul-3 經濟部中央標準沁M工消忉合作社印5i 32809H),2212ΠΝ)、1621,1597, 1570, 1527, 1490, 1346, 1310、1130(sr1110, 1090, 892, 829 3 3 603Γ3 3 22 (mr2 2 00{mr1710(sr157s(sr152 4 (sr14 299r 14 09 (s),1348 (3),1318 (mr1275{s),12413),1189(3),1107 (mr 1081 (m)'vo853),8943),7633) 3300, 2920, 2840, 2200, 1660, 1580, 1510, 1450,1345, 1305、 1260,124 0,1175,1065,103 5、9CO0,915'CO90,870, S5,820,805,7 60 3 29-P2905,2820,221,°157 5,1550,1505,14 60,14 3 5,1410,1395, 13 55、129 0、1270,12 5°1225,1160,1130,1080,102 0,89 0,84-PB05, 760,710, so, 680 32VO0, 2200, 1U16U1, 1520, 1^90, 1^^0, 1^05, 13030, 13 办 0, 1305、 1250, 1230, 11B0, 1080, 1040, 995, 885, 865, 810, so 3280, 220U1, 1570, 1U12U1, 一 办 BU1, 13VO5, 1360, 130U1, 1280, 123U1, 10B°106,0VO7°009-.°815, 7 60,65 3290(s),2210(s),1610(3),1570(sr1525 (sr1410(sr .133°.sr'124°.sris 2220,1560, 1460, 1380, 1320,1170, 1130, 1050 3260, 2970, 2210, 1910, 1590,1410, 1350, 1300, 1270, 1195、 112 0,1095、1070,102 0,99 5,950,905,87 0,84 0,82 5,805,770,73-P675 >1 {基}令J Ar R2. R1裔一.c 貧#择:c^雖(陶米丨二) ...............t .......夢..…. (請先IU1請背而之注"意事項#*填耗本贾) 一 χ Λ- 一 本紙張尺度边用中B國家楳準(CNS)«P4規tM210x297公:«:) 五、發明説明(y) t*J U) U> cdAAAAAA person AAA 108,5-110 179 丨 81; Ml-2 12Ϊ 16Ϊ 158-60 188-vd 1-05101 10Ϊ; Ul-3 Central Ministry of Economic Affairs Qin M Industry and Consumers Cooperative Society printed 5i 32809H), 2212ΠΝ), 1621 , 1597, 1570, 1527, 1490, 1346, 1310, 1130 (sr1110, 1090, 892, 829 3 3 603Γ3 3 22 (mr2 2 00 (mr1710 (sr157s (sr152 4 (sr14 299r 14 09 (s), 1348 (3 ), 1318 (mr1275 {s), 12413), 1189 (3), 1107 (mr 1081 (m) 'vo853), 8943), 7633) 3300, 2920, 2840, 2200, 1660, 1580, 1510, 1450, 1345 , 1305, 1260,124 0,1175,1065,103 5,9CO0,915'CO90,870, S5,820,805,7 60 3 29-P2905,2820,221, ° 157 5,1550,1505,14 60,14 3 5,1410,1395, 13 55,129 0,1270,12 5 ° 1225,1160,1130,1080,102 0,89 0,84-PB05, 760,710, so, 680 32VO0, 2200, 1U16U1, 1520, 1 ^ 90, 1 ^^ 0, 1 ^ 05, 13030, 13 Office 0, 1305, 1250, 1230, 11B0, 1080, 1040, 995, 885, 865, 810, so 3280, 220U1, 1570, 1U12U1, one office BU1 , 13VO5, 1360, 130U1, 1280, 123U1, 10B ° 106, 0VO7 ° 009-. ° 815, 7 60,65 3290 (s), 2210 (s), 1610 (3), 1570 (sr1525 (sr1410 (sr. 133 ° .sr'124 ° .sris 2220,1560, 1460, 1380, 1320 , 1170, 1130, 1050 3260, 2970, 2210, 1910, 1590,1410, 1350, 1300, 1270, 1195, 112 0,1095, 1070,102 0,99 5,950,905,87 0,84 0,82 5,805,770,73- P675 > 1 {基} 令 J Ar R2. R1 族 一 .c 無 #Optional: c ^ though (Tao Mi 丨 Two) ............... t .... ... Dream ...... (please note IU1 first " 意 事 # * Fill Ben Jia) one χ Λ- a paper scale for the Chinese National Standard B (CNS) «P4 regulations tM210x297 Public: «:) 5. Description of the invention (y) t * JU) U > cd

OJOJ

U) U) LJ U> N) M β CDC13 - 15.62(1H、S); 7.66(2H、d); 7.58(2H,d); 2.16(153); 1.35(2H,m);r19(2H,mr192,51; 167.s; 138.71; 137.41; 129.39 (q、J=309HZ); 121.41; 120-40; 15.91; 11.19 CDC13 - 1.14-1.25(2H,m); 1.31-1.41(2H,mr 2.10-2.20(lH、mr3.92(3H,s); 7.59(2H,d,J=8,6 Hz) ; 7 .66( 1H,S) ; 8- 05( 2H'd,J=co,4);15.s{lH,s) DMSO - 11· 86(1H,S) ; 7.92(25mr7.69(2H,m); 2.52(3H,m); 2-17(lH,m); 0.8B(4H,m) DMSO - 10.44(1H,S); 7.22(lH,m); 7 .11( 6.95(153) ; 3.76(6H,S) ;2.19(lH,mr1.07(4H,E DMSO - 11.21(1H、S); 7.81(1H、S); 7.28(2H,S); 2.30(3H,S); 2.19(153); 0.98(lH,m) DMSO - 10.66(1H,s); 7.52(2H,m); 7.27(2H,m); 2.52(3H,S); 2.20(lH,m); l.o6(4H,m) DMSO 丨 10.65(1H,S); 7.37(2H,3); 7.26{lH,3r 6.97(153) ; 2,32( 3H,S) ; 2.19( 1H,3) ; 1,08( 4H,m) (請先閲請背而之注意亊項#蜞寫本頁) 裝· 線· C15H14N203 270.29 C15H16N204 288.31 C14H13C1N202 276.72 C14H1厶M202S 274 k 01554^20^ 286-29 C17H20N2O2 284 ’ 36 C14H14N202 2-^2. 28 014^11^3^2025 328,32 經濟部屮央榀準·hA工消价合作社印製 61.sw.一办 10.21 11.69 6°77 4 .74 !ιο·12 12,81 62.49 5.59 9.72 66.66 5.22 1Ρ36 62·93 4,93 9·78 山77 51.22 3·38 8·53 17·36 69.办一 ^.82 11,56 71.81 *7.g,35 格 規 4· T \—/ S CN 準 家 國 a 中 用 边 度 尺 張 紙 本 五、發明説明(Μ·)U) U) LJ U > N) M β CDC13-15.62 (1H, S); 7.66 (2H, d); 7.58 (2H, d); 2.16 (153); 1.35 (2H, m); r19 (2H, mr192,51; 167.s; 138.71; 137.41; 129.39 (q, J = 309HZ); 121.41; 120-40; 15.91; 11.19 CDC13-1.14-1.25 (2H, m); 1.31-1.41 (2H, mr 2.10- 2.20 (lH, mr3.92 (3H, s); 7.59 (2H, d, J = 8,6 Hz); 7.66 (1H, S); 8- 05 (2H'd, J = co, 4) ; 15.s {lH, s) DMSO-11.86 (1H, S); 7.92 (25mr7.69 (2H, m); 2.52 (3H, m); 2-17 (lH, m); 0.8B ( 4H, m) DMSO-10.44 (1H, S); 7.22 (lH, m); 7.11 (6.95 (153); 3.76 (6H, S); 2.19 (lH, mr1.07 (4H, E DMSO-11.21 (1H, S); 7.81 (1H, S); 7.28 (2H, S); 2.30 (3H, S); 2.19 (153); 0.98 (lH, m) DMSO-10.66 (1H, s); 7.52 (2H , m); 7.27 (2H, m); 2.52 (3H, S); 2.20 (lH, m); l.o6 (4H, m) DMSO 丨 10.65 (1H, S); 7.37 (2H, 3); 7.26 {lH, 3r 6.97 (153); 2,32 (3H, S); 2.19 (1H, 3); 1,08 (4H, m) (please read first, please pay attention to 亊 项 # 蜞 write this page) Installation · Line · C15H14N203 270.29 C15H16N204 288.31 C14H13C1N202 276.72 C14H1 M202S 274 k 01554 ^ 20 ^ 286-29 C17H20N2O2 284 '36 C14H14N202 2- ^ 2. 28 014 ^ 11 ^ 3 ^ 2025 328,32 The Ministry of Economic Affairs, the central government, printed by the hA industrial consumer price cooperative 61.sw. 1 Office 10.21 11.69 6 ° 77 4 .74! 12 12,81 62.49 5.59 9.72 66.66 5.22 1Ρ36 62 · 93 4,93 9 · 78 Mountain 77 51.22 3 · 38 8 · 53 17 · 36 69. Office 1 ^ .82 11,56 71.81 * 7.g, 35 Specification 4.T \ — / S CN quasi-home country a with a ruler on paper V. Description of the invention (Μ ·)

U) VD DMSO - 11.82(1H,S-NH);8.00(lH、d,J=9HZ,H—5); 7.71(lH、dd,J=9HZ,J=2HZ,H-6) ;7·63 (lH,d,J"2HZ, H-2) ; 2.91(25q,Jm7. 4HZm.thyl-CH2) ; 2.28-2.16 (l?m,cyclopropyl 1—Hi ;1· 24 (3H,t,JH7.4Hz, -CH3);0·97-0.87 (4H、m,cyclopropyl j 0DC13 - 16.99(1H,S); 7.69(lH、d); 7.23(2H,d); 3,37(3H,S); 2.53(3H,S);2.14(lH、m) ;1.15(4H,m) n16K15F3z2〇2 324.31 C:15H15N3〇4 301.30 Λ 6 Π 6 (請先閲讀背而之注意事項再蜞寫木頁) 裝. 訂- 線. 經濟部屮央標準而β工消*:合作社印3i 59.26 4·66 8·64 M7·57 59.80 5.02 13.95 c«w>5 料-+½:3m: ΧΛ> 本紙尺度遴用中SB家標準(〇旧)肀4規(Λ(210χ2ί)7公tf) 7ί42 ο 6 6 ΛΠ 經濟部十央標準·Χ;Η工消1Ϊ-合作杜印製U) VD DMSO-11.82 (1H, S-NH); 8.00 (lH, d, J = 9HZ, H-5); 7.71 (lH, dd, J = 9HZ, J = 2HZ, H-6); 7. 63 (lH, d, J " 2HZ, H-2); 2.91 (25q, Jm7. 4HZm.thyl-CH2); 2.28-2.16 (l? M, cyclopropyl 1-Hi; 1.24 (3H, t, JH7 .4Hz, -CH3); 0.97-0.87 (4H, m, cyclopropyl j 0DC13-16.99 (1H, S); 7.69 (lH, d); 7.23 (2H, d); 3,37 (3H, S) ; 2.53 (3H, S); 2.14 (lH, m); 1.15 (4H, m); 1.15 (4H, m) n16K15F3z2〇2 324.31 C: 15H15N3〇4 301.30 Λ 6 Π 6 (please read the precautions before writing the wooden page) Pack. Order-line. Ministry of Economic Affairs standard and β work consumption *: Cooperative printing 3i 59.26 4 · 66 8 · 64 M7 · 57 59.80 5.02 13.95 c «w > 5 material- + ½: 3m: ΧΛ > Use the Chinese SB standard (〇 old) 4 rules (Λ (210χ2ί) 7g tf) 7ί42 ο 6 6 ΛΠ Shiyang standard of the Ministry of Economics Χ; Η 工 消 1Ϊ-cooperative du printing

(請先閲讀背而之注*'事項#-填窍木頁) 裝- 線· 本紙5fc尺度边用中a Η家楳半(CNS) Ή規怙(2l0xWY/,:>) Ο Λ 6 Π 6 五、發明説明 03 〇\ Μ CDC13 - 16.75( 1H,S); 7·76(2Ηα); 7.37 (2Har· 3.39(3H,S); 2.10(lH,m); 1.18(4H,m) SC13 - 16.69(1H,S); B.33(2H,d);7. 45MH、dr 3.42(3H,S); 2.10(lH,pentet); l.ls(4H,m) CDC13 - 15.70(1H,S); 7.48(lH,sr7.33(4H、3); 2.32(3H,S);2.12(3H、S);1.31(2H,m);1.17(2H,3} CDC13 - 15.62(lH,s);7.62(lH,s);7.46(3H,m); 2 - 49 (3H, t,J=3HZ) ; 2. 13 (lH,m) ;1 ·34 (2H,3); 1, 19 (2H,m) CDC13 - 17,16(1H,S); 7.60(lH,d); 7.13(lH、d); 6.96(lHad); 3.30(3H、sr2.44(3H,sr 2.13ilH>pentet); 1.13(4H,m) CDC13 - 15_82(1H,S,0H); 7-57(lH,s,-NHr 7.31-7.26(3H、m,aromatic ..r2.75(2H、q,J=6HZ, ethyl -CH2r2-.18-2'oB {lH,m, cyclopropyl l-Hrll\36-l,10(4H,m,cyclopropyl.); 1.24 (3H、t,J=7.sz,6thyl. -CH3) SC13 - 15.72(1H,S); 7.54(1H,S); 7·33(3η,3γ. 2.32(3H,S) ; 2 .15(153) ;l,33(2H,mr1.17(2H、m) > (請先閱讀背而之注·意I項#填窍木頁) 裝· 訂' C14H122:2〇^ 272 .26 C15K15C12202 290.7U1 C15H15B1TN2〇2 335.21(Please read the back note * 'Item # -filling the wood page first) 装-线 · 本 纸 5fc scale side-use middle a Η 極 楳 半 (CNS) Ή 規 怙 (2l0xWY /,: >) Ο Λ 6 Π 6 V. Description of the invention 03 〇 \ Μ CDC13-16.75 (1H, S); 7.76 (2Ηα); 7.37 (2Har · 3.39 (3H, S); 2.10 (lH, m); 1.18 (4H, m) SC13-16.69 (1H, S); B.33 (2H, d); 7.45MH, dr 3.42 (3H, S); 2.10 (lH, pentet); l.ls (4H, m) CDC13-15.70 (1H , S); 7.48 (lH, sr7.33 (4H, 3); 2.32 (3H, S); 2.12 (3H, S); 1.31 (2H, m); 1.17 (2H, 3) CDC13-15.62 (lH, s); 7.62 (lH, s); 7.46 (3H, m); 2-49 (3H, t, J = 3HZ); 2. 13 (lH, m); 1.34 (2H, 3); 1, 19 (2H, m) CDC13-17,16 (1H, S); 7.60 (lH, d); 7.13 (lH, d); 6.96 (lHad); 3.30 (3H, sr2.44 (3H, sr 2.13ilH >pentet); 1.13 (4H, m) CDC13-15_82 (1H, S, 0H); 7-57 (lH, s, -NHr 7.31-7.26 (3H, m, aromatic ..r2.75 (2H, q, J = 6HZ, ethyl -CH2r2-.18-2'oB {lH, m, cyclopropyl l-Hrll \ 36-l, 10 (4H, m, cyclopropyl.); 1.24 (3H, t, J = 7.sz, 6thyl .-CH3) SC13-15.72 (1H, S); 7.54 (1H, S); 7.33 (3η, 3γ. 2.32 (3H, S); 2.15 (153); 1,33 (2H, mr1. 17 (2H, m) > (please read the note on the back first · I item #filling the wood page) Binding · Order 'C14H122: 2〇 ^ 272 .26 C15K15C12202 290.7U1 C15H15B1TN2〇2 335.21

C15H13N302 267. 2VD C14H13N304 2037. 28 C15H13F3N203 326.28 C16H13F5N202 360.2VO clulHlurorF^NWOS 387.19 線· 61.7ch办1Ρ29 61.9-7 5·20VO.63 12,19 53.701办·UIM 3,3σ\23·84 53·:Μ 3·6 办 7.7OT 26·37 55.22 4.02 8.59 17.47 58. 53 4 · 56 14 .63 67.办一 办.νοο 15.72 9.81 46.53 3.38 7.24 20.2 ΚΛ> ««>#> -8 本紙5k尺度边用中as家樣毕(CNS)TM規格(210x297公;《:) 經濟部屮央榀準局Π工消奸合作社印31 Λ fi Π 6 五、發明説明(ο) 藥理活忡: 牛仆.奮賒方法 試驗 1 鹿#莖引祀:> 老鼠g蓳浮睡(Ρ Π - R ) 使每群(6-12隻)老鼠(CFHB雄性,體重160-18Q克)口 服試驗化合物或對照之攜體後,自右後足底肉趾注人1 毫克鹿角菜/ 0.2毫升鹽水溶液。在對照的足掌注入空 白的鹽水。3小時後,評估足掌浮腫反應。 試驗 2 "征醒型渦敏”白鼠:> 兄堂淨睡 Π) T Η - Μ ) 使每群(8至10住)白鼠(雄性CD-1,體重25-30克)由皮 下注入1毫克”甲基化牛血清蛋白”(MBSA)/0.2毫升鹽 水和”佛羅因德氏”完全輔劑(F C A )之乳化液引起過敏。 對照群則只注入鹽水/ F C A乳化液。過敏化7天後自右 後足底肉趾注入0.1毫克 MBSA/0.05毫升鹽水,又經1 天後,評估DTH足掌浮腫反應。對照的足掌則只注入空白 的鹽水。在注入MBSA —小時前.6小時後.以及第4. 5, 6,天口服一次.在第7天口服兩次試驗化合物或 對照攜*。 》 a:4Ja__iC15H13N302 267. 2VD C14H13N304 2037. 28 C15H13F3N203 326.28 C16H13F5N202 360.2VO clulHlurorF ^ NWOS 387.19 Line · 61.7ch office 1P29 61.9-7 5.20VO.63 12,19 53.701 office · UIM 3,3σ \ 23 · 84 53: · 6 Office 7.7OT 26 · 37 55.22 4.02 8.59 17.47 58. 53 4 · 56 14 .63 67. Office One Office. Νοο 15.72 9.81 46.53 3.38 7.24 20.2 ΚΛ > «« ># > -8 This paper is used for 5k scale CNAS Standard Specification (210x297); ":) The Ministry of Economic Affairs, the Central Bureau of Economics and Social Security, Π 工 旻 見 社會 社 記 印 31 Λ fi Π 6 V. Description of the invention (ο) Pharmacological activity: cattle servant. Fen Credit method test 1 Deer # Stem Introduce:> Rat g-float (P Π-R) Make each group (6-12) rats (CFHB male, weight 160-18Q g) orally carry test compounds or controls After the body, 1 mg of carrageenan / 0.2 ml of saline solution was injected from the right hind sole. Inject blank saline into the sole of the control. After 3 hours, the paw edema response was evaluated. Test 2 " Wake-up vortex-sensitive white mice: > Xiongtang net sleep II) T Η-Μ) Each group (8 to 10 live) white mice (male CD-1, weight 25-30 grams) were injected subcutaneously 1 mg of "Methylated Bovine Serum Albumin" (MBSA) /0.2 ml of saline and "Freund's" complete adjuvant (FCA) emulsion caused allergy. The control group was injected with saline / FCA emulsion only. Seven days later, 0.1 mg of MBSA / 0.05 ml of saline was injected from the right posterior plantar toe, and after another day, the DTH paw edema reaction was evaluated. The control sole was injected with blank saline. Before the injection of MBSA-hour. After 6 hours. And on days 4, 5, 6, orally once. On the 7th day, the test compound or control was taken orally twice.》 A: 4Ja__i

征臛型過敏老E之_足」湛_淫_8^_1丨).1·丨丨二RJL 使毎群(8至1 2雙)老E ( C F Η B雄性.體Μ 1 6 0 - 1 8 0克)由 尾巴基部皮下注入〇 . 1毫升F C A ,引起過敏。對照群刖注 入彿羅氏不完全軸劑。過敏化第7天自右後足底肉趾注 人 . 4毫克结核菌荦取抗原/ 〇 . 2毫升鹽水.又绊2 4小時 -2 9- 本紙张尺度边用中國S家榀毕(CNS)IM規格(210x297公放) (請先閱筇背而之注意事項再艰寫本頁) 裝· 線·Symptom-type allergy old E Zhi _ Zhan_ kinky_8 ^ _1 丨) .1 · 丨 丨 Two RJL make every group (8 to 12 pairs) old E (CF Η B male. Body Μ 1 6 0- 180 g) 0.1 ml of FCA was injected subcutaneously from the base of the tail, causing allergy. The control group was injected with Freund's incomplete axis agent. On the 7th day of the allergic reaction, the human toes were injected from the right rear sole. 4 mg of tuberculosis bacteria antigen / 0.2 ml of saline. Another trip 2 4 hours-2 9- This paper is scaled with Chinese SJ (CNS ) IM specifications (210x297 public) (Please read the notes before you write this page hard) Install · Line ·

五、發明説明(β) - 後,評估D Τ Η足掌浮腫反應。對照足掌則只注入空白的 鹽水。 在注入抗原的前1小時,6小時後,以及第4 , 5 , 6天口 服一次及在第7天口服兩次試驗化合物。 試驗结果列於表II。劑量單位為毫克/仟克口服。 (請先閲筇背而之注意事項孙蜞寫本頁) 裝· 線. 本紙尺度逍用中a國家详iMCNS)lM規«(210x297公坫) 五、發明説明(>,) 經濟部屮央標準·知=3工消货合作社印製5. Description of the invention (β)-After the evaluation of D Τ Η foot edema reaction. The control sole was injected with blank saline. The test compound was taken orally 1 hour before, 6 hours after the injection of the antigen, and on the 4th, 5th, and 6th days, and twice on the 7th day. The test results are listed in Table II. The dosage unit is mg / g orally. (Please read the note on the back of this page first. Sun Yao writes this page) Installation · Line. This paper is used in a small country iMCNS) lM regulations «(210x297 Gonghe) V. Description of invention (>,) Ministry of Economic Affairs Central Standard · Knowledge = 3 Printed by Cooperative Society

Η» Η1 Η» M CJtOMOVDOOOONUI^CJiOH· t-iCDCJliOVD^rOtO^MUJW^ 抑制半 試驗1 _ | (50) i (50) (50) (50). 1 (50) (50) 1 (50) (50) (50) (50) (50) (50) (50) • 劑量 O^CD〇\CD(^〇N^JOU1 uicd VD^Cn^〇lVD^O>VDCD^LnUl 抑制率 <Η> 試驗2 (30) (100) (100) (100) (30) (30) (30) (30) (30) (30) (100) (30) (100) 劑量 53 25 -1 19 i 46 74 61 53 104 30 66 39 22 抑制率 試驗3 (10) (50) (50) (50) (10) (3) (3) (3) (3) (10) (50) (10) (10) 劑量 >II ................(.......裝.....!1·..線 (請先1«]讀背而之注^'事項#-填^本頁) 本紙5fc尺度边m中s s家详準(CNS)〒4規格(210x2W/i^ Λ 6 Η 6 經濟部中央標準而Η工消作合作社印製 發明説明(w) LOLOtOtOtOtOtOMMH-K»»-» CJ〇〇)^J〇NUl〇VDOD〇%CJt^. 1 U) t U) u> to to ^ CJ to «ooDroio^ooM^ONCTk^cr» 抑制半 (50〉 (50) (50) (50) (50) (50) (50) (50) (50) (50) (50) (50) 登 1φ Η VD^-CT\〇\U1〇3^U)^J〇DU1^J 抑制半 to (100) (30) (30) (30) (30) (30) (30) (100) (30) (30) (10) (3) 剞量 CJMUl^UiCn^O^^CT»·^ V〇u>〇j_»〇VDfO·^ 、JOD、JVO 抑制半 η (10) (50) (10) (10) (50) (10) (10) (10) (10) (10) (30) (30) 劑量 U) A II (荔-) ...............* .......裝.....玎 線 (請先Ml-ift背而之注^*事項#-填寫本頁) 本紙5J:尺度边用中國S家標準(CNS)TM規格(210x297公;《:Η »Η1 Η» M CJtOMOVDOOOONUI ^ CJiOH t-iCDCJliOVD ^ rOtO ^ MUJW ^ Inhibition half test 1 _ | (50) i (50) (50) (50). 1 (50) (50) 1 (50) ( 50) (50) (50) (50) (50) (50) • Dose O ^ CD〇 \ CD (^ 〇N ^ JOU1 uicd VD ^ Cn ^ 〇lVD ^ O > VDCD ^ LnUl Inhibition rate < Η > Trial 2 (30) (100) (100) (100) (30) (30) (30) (30) (30) (30) (100) (30) (100) Dose 53 25 -1 19 i 46 74 61 53 104 30 66 39 22 Inhibition rate test 3 (10) (50) (50) (50) (10) (3) (3) (3) (3) (10) (50) (10) (10) Dosage > II ................ (....... installed .....! 1..line (please first 1 «) read back Note ^ 'Item # -fill ^ this page) ss home standard (CNS) 〒 4 specifications (210x2W / i ^ Λ 6 Η 6 central standard of the Ministry of Economic Affairs and printed by the HC Gongxiao Cooperative Society) (W) LOLOtOtOtOtOtOMMH-K »»-»CJ〇〇) ^ J〇NUl〇VDOD〇% CJt ^. 1 U) t U) u > to to ^ CJ to« ooDroio ^ ooM ^ ONCTk ^ cr »Inhibition half ( 50〉 (50) (50) (50) (50) (50) (50) (50) (50) (50) (50) (50) Den 1φ Η VD ^ -CT \ 〇 \ U1〇3 ^ U ) ^ J〇DU1 ^ J Suppression half to (100) (30) (30) (30) (30) (30) (3 0) (100) (30) (30) (10) (3) 剞 量 CJMUl ^ UiCn ^ O ^^ CT »· ^ V〇u> gt; 〇j_» 〇VDfO · ^, JOD, JVO inhibition half η (10 ) (50) (10) (10) (50) (10) (10) (10) (10) (10) (30) (30) Dose U) A II (Li-) ....... ........ * ....... 装 ..... 玎 线 (please note Ml-ift first ^ * Item # -fill in this page) 5J of this paper: China S home standard (CNS) TM specifications (210x297 g; ":

Claims (1)

六、申請專利範圍 第8010915S號「3 -琿烷基-丙瑟技衍生物」專利案(82年2月修正)1.如下列化合物(I)及其鐮加成蘧:6. Scope of Patent Application No. 8010915S "3-Hunyl-Prosperyl Derivatives" Patent Case (Amended in February 1982) 1. Such as the following compound (I) and its sickle addition: (請先閲讀背面之注意事項再塡寫本頁) 絰濟部中央標準局員工消費合作社印¾ 式中β i傜C,- 6環烷基; R2偽氫原子或Ci- 3烷基;R3 之一取代基表氫原子或。-*烷基,另一取代基表氫原子:,R5及Re之一取代基表氫原子,其它二餹可為相 同或不同,各傜氳原子,豳原子,躋基,-N02 ,直鰱或分枝 療子,窗原子,猜"'基,-κο2 .直鐽或分枝、 C 1 - 6烷基,直鐽或分技Cl - ε烷氣基,C:t- ε 烷硫基,C 0 R 1基(其中Κ _傜羥基,C 1 s烷基或烷氛 基),或選自 -切山-%' _〇-(CH山-CF3, -S-(CH上-CF3, 。 /F -、-F2_Hal, -0_-CF2_Hal, -(CF2)n -c -Hal1、Η3ΐ2 :裝. .ΤΓ 太紙乐只適用士同同定埤並f Γ\· C、,扣R Λ W '、八、(Please read the precautions on the back before writing this page) Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ where β i 傜 C, -6 cycloalkyl; R2 pseudo hydrogen atom or Ci-3 alkyl; R3 One of the substituents represents a hydrogen atom or. -* Alkyl group, another substituent represents a hydrogen atom: one of R5 and Re substituents represents a hydrogen atom, the other two can be the same or different Or branched therapy, window atom, guess " 'group, -κο2. Straight or branched, C 1-6 alkyl, straight or branched Cl-ε alkyl gas group, C: t- ε alkyl sulfide Group, C 0 R 1 group (where _ _ 傜 hydroxyl group, C 1 s alkyl or alkyl group), or selected from-cut mountain-% '_〇- (CH mountain-CF3, -S- (CH on -CF3 , ./F-, -F2_Hal, -0_-CF2_Hal,-(CF2) n -c -Hal1, Η3Ι2: installed .. ΓΓ Taizhile is only applicable to the same as the same fixed f Γ \ · C, buckle R Λ W ', eight, 六、中 (其中 m 係 〇,1,2或 3; η 傜 1,2,或 3; Hal.Hali ,Hal2 .及Hal3可為相同或不同,各為鹵原子);或 R 4 ,及R 5 — 起 % -0 -C Η 2 一 0 - > 而 R 3 , R 6及 R 7*^ 傜如 前 者 〇 根 據 ψ 請 專 利 範 圍 第 1 項 之 化 合 物 1 式 中R H ,R 4 , R ,R 6 及 R 7可為相同或不同, 傜氫, 氣, 氯, m 或碘 原 子 1 甲 基 乙 基 t 第 二 丁 基 甲 氣 基 ,甲 硫基,三 氧 甲 基 » 三 氟 甲 π 基 > 三 氣 甲 硫 基 ) 五 氟乙 基, 溴二 氧 甲 氣 基 » 乙 Μ « 羥 羧 基 甲 氣 m 基 » 硝 基, 或 m 基 : 或 R ^ ,及R 5 — 起 -0 -C Η : 2 ~ 0 - ,而 彐 , R ·4及 R, ,如商 ΐ述; ;R 2 氫 原 子 或 甲 基 * 及 R 1 如申讅 専利 範 園 第 1 項 中 所 述 者 〇 根 據 Φ 請 專 利 範 圍 第 1 或 2 項 之 化 合 物 ,式 中 {沐先5?^背而之注意事項再填荈本百 ·-.. 抆濟部屮央標苹As工消脅合作杜印虹 R i係環丙基; R 2偽氫原子或甲基; R3 ,R4 ,RS ,)?6及尺?可為相同或不同,傜氫,氣, 氮或碘原子,甲基,^02或-0『3者。 4 .根柹申誘孬利《5圍第1項'之化合物,選自: 1 -( ‘丨-硝苯胺S Φ餡)-2,琛丙基-2 -瓴丙脱; 1 - ( 4 - m芣胺基甲罔)-2 -琛丙基-2 -瓴丙眧; 1 - U -簌-3 -甲苯胺基甲S ) - 2 -環丙基-2 - Μ丙脂; 1 - ( 3 -甲基-4 -三截甲苯胺基甲ΒΞ ) - 2 -琛丙基-2 -氧丙腈 1 - ( 4 -镊-3 -甲苯忮基甲藍)-2 -現'丙基-2 -氣丙脂; —2 — •打· " 木认:t K玟坫川十 K W SUT:平(CNS),p (210 X 29?公公) A7 B7 C7 D7 六、申請專利範圍 5· —種製備如申請專利範園第1項所逑之化合物Π)之 方法,像由化合物(II)中所列舉者Six, in which m is 〇, 1, 2 or 3; η 傜 1, 2, or 3; Hal. Hali, Hal2. And Hal3 may be the same or different, each is a halogen atom; or R 4 and R 5 — From% -0 -C Η 2 一 0-> R 3, R 6 and R 7 * ^ 傜 as the former. According to ψ, the compound 1 of the first item of the patent scope, where RH, R 4, R, R 6 and R 7 may be the same or different, hydrogen, gas, chlorine, m or iodine atom 1 methylethyl t second butyl methyl group, methylthio, trioxymethyl »trifluoromethyl π group> Three gas methylthio) pentafluoroethyl, bromodioxymethyl gas »ethyl« hydroxycarboxymethyl gas m group »nitro, or m group: or R ^, and R 5-from -0 -C Η: 2 ~ 0-, and 彐, R.4 and R, as described in the business ;; R 2 hydrogen atom or methyl group * and R 1 as described in Item 1 of the Shen Fan Fan Garden 〇 Patent according to Φ The compound of item 1 or 2 of the scope, in the formula {Mu first 5? ^ Contrary precautions and then fill in this book.-.. 抆 济 部 屮 央 标 标 As Industrial and consumer cooperation Du Yinhong R i is cyclopropyl; R 2 pseudo hydrogen atom or methyl; R 3, R 4, RS,)? 6 and ruler? It can be the same or different, 3 hydrogen, hydrogen, nitrogen or iodine atom, methyl, ^ 02 or -0. 4. Based on the application of the compound "5 surrounding item 1", selected from: 1-('丨 -Nitroaniline S Φ filling) -2, Chen propyl-2-propanol; 1-(4 -m-fluorenylmethylmethine) -2-Chenpropyl-2-fenpropanil; 1-U-簌 -3-tolylaminomethyl S)-2-cyclopropyl-2-Μpropyl ester; 1- (3 -Methyl-4 -tris-toluidinemethyl BΞ)-2 -Chenpropyl-2 -oxypropionitrile 1-(4-Tweezer-3 -Tolylmethyl blue) -2 -Now'propyl -2 -Gas propylene fat; —2 — • Hit: " Mu recognized: t K 玟 坫 川 十 KW UT SUT: Ping (CNS), p (210 X 29? Public father) A7 B7 C7 D7 Six, apply for patent scope 5 · A method for preparing the compound Π) as described in item 1 of the patent application garden, as listed in compound (II) £ CN 0 (II (請先《尊面之注意事項再塡寫本頁) 中 式 任 中 項 3 至 納 R 化 及氫 β 和 R » V)#. S 義 R,定 * 所 R,項 圍 範 利 * 請 Φ 如 如 媒 觸 在 時 要 必 物 合 化 和 fit 間 中 得 所 使 著 接應 反 下 在 存 之 唑 眯 之 得 應 反 所 中 項 1A 第 匾 範 利 專 諳 申 如 X R 而 子 原 0 0 IX a Η 中 式 範 利 専 請 '申 如 中 (I其 物 , 合法 化製 得之 所項 使 5 法第 常圔 依範 ,利 時專 要請 必申 據 述根 6. 鹽 成 加 錄 成 變 轉 -裝. 訂. .嫁.. 經濟部中央標準局R工消费合作杜印製 物 合 化 之 0 項行 5 進 第中 園喃 呋 氫 四 水 無 在 0 反 之 納 化 氫 和 範 利 專 讅 申V) 如(I 中物 其合 ,化 法列 製下 之由 項是 5I) 宾 I 鏵 ( 臞物 範合 利化 專之 誧項 申 5 據第 根圍 本紙張又度適用中國國家標準(CNS)甲4规格(210 X 297公釐) 六、申請專利範園£ CN 0 (II (please pay attention to the face before writing this page) Chinese Renmin term 3 to accept R and hydrogen β and R »V) #. S 义 R, 定 * 所 R, 项 围Fan Li * Please Φ If the match is in the middle, it must be a combination of the compound and the fit, and the response will be reversed. The existing squint should respond to the midterm of the institution. 1A The plaque Fan Li specializes in Shen Ru XR and子 原 0 0 IX a Η Chinese-style Fan Lizhe please 'Shen Ruzhong (I its thing, the legally obtained items make the 5th law often follow the norm, and Li Shi specifically needs to apply for the stated root 6. Salt into Add to change to change. Ordered. Married .. Central Bureau of Standards of the Ministry of Economic Affairs R-Consumer Cooperation Du-printed chemical compound 0 item line 5 into the middle of the park. Furfuran tetrahydrate is not in 0. On the contrary, it is hydrogen and vanadium. Li Zhuan Shen V) Such as (I in the combination of things, the legal term is 5I) Bin I Hua (Fu Wu Fan He Li Hua Zhi Zhi Xiang Shen 5 according to the root of this paper is also applicable China National Standards (CNS) Grade A 4 (210 X 297 mm) A7 B7 C7 D7 (IV) (式中R2 ,R3 ,I?4 ,R5 ,RS及尺7如第i項中所述)和下列 化合物【V)或其官能衍生物[反應而得, A CN (V) (請先閲讀背面之注意事項再填寫本頁) HO Ο 中或基 其)I己,(v« 法物二 製合或 之化胺 項和亞 7V)— 第 Π 化 B物硪 範合基 利化丙 專之異 請項二 申 7 在 據第應 根圍反 8 IgL 之 利^Is »!(7Jffi 謫s二 Ϊ 翔 -J 申官ί 進 中 烷 甲 氰 二 或 喃 呋 氳 四 如 剤 溶 機 有 水 無 於 下 在 〇 存行 法 製 之 項 8 或(V 7 物 第合 函化 範之 利項 專 7 謫第 申圍 據範 根利 9 專 誚 甲 如 中 其 氯0 乙 氰 是 物 生 衍 能 官 之 -裝. 訂. 經濟部中央揉準局W工消費合作社印製 由 是 氰 醯 乙 氰 中 其 法 製 之 項 9 第 圍 範 利 專 請 Ψ 據 根 得 製 場 現0 化 氯 五 和 酸 醋 氰 加0 可 許 mh£ 理0 其 或 物 合 化 之 項 .1—Η jAra 0 圍 範 利 專 謓 Φ 雄 根 者 物 蕖 為 用 可 鹽 成 本紙張又度適用中國國家標準(CNS)甲4规格(210 X 297公釐) 六、申請專利範園 A7 B7 C7 D7 0 可 許 I: 理 蕖 其 或 物 合 化 之 項 1 第 圍 範 利 專 請 Φ 據 根 用 之 蕖 炎 消 造 製 於 用 偽 鹽 成 加0 可 許 理0 其 或 物 合 化 之 項 第 園 範 利 專 誚 Φ 據 根 或 性 疫 免 及 炎 節 關0 風 療 治 C 以用 物之 蕖炎 造發 製性 於慢 用之 傜性 ,疫 鹽免 成非 濕 風 療 炎第 發圍 物 成 組式 ZU ί .學之 用· •的 CB rft 種 藥項 合 化 ¾含 * ※像, ® Μ或 關 物 性 疫 少 至 可 理 性 慢之 i a tt ^ ^ SM 加 ^如 * 非1$|受 或 接 範 利 C請先閲f面之注意事項再瑣寫本頁) 0 形 賦 或 \ 及0 釋 稀 鼸 攜 受 接 可 1-* 理0 6Ε a 多 或 種 物 合 化 列 下 如A7 B7 C7 D7 (IV) (where R2, R3, I? 4, R5, RS and ruler 7 are as described in item i) and the following compound [V] or its functional derivatives [from reaction, A CN (V) (Please read the precautions on the back before filling in this page) HO Ο In or based on it) I, (v «Law of the two compound or the chemical amine and sub 7V)-Π B The difference between Fanhejili and Chuangzhuan, please apply for the second application 7 in accordance with the first anti-8 IgL benefit ^ Is »! (7Jffi 谪 s 二 Ϊ 翔 -J 申 官 ί enter the middle alkyl cyanide or furan氲 四 如 剤 湤 机 有 水 不下 下 Deposit legal item 8 or (V 7 物 合 合 化 范利利 专 专 7 鰪 第 申 围 講 范根利 9 Specializes in the use of its chlorine 0 B Cyanogen is the product of the bio-energy officer. Ordered. Printed by the Ministry of Economic Affairs Central Bureau of Industry and Commerce W Co., Ltd. Consumer Cooperatives. It is the cyanide ethyl cyanide in its legal system. 9th Fan Fanli Special Request Ψ According to the production site 0 Chlorine pentahydrate and acid vinegar cyanide plus 0 allowable mh £ rational 0 or its combination of items. 1—Η jAra 0 國 范利 专 謓 Φ The roots are the roots Saltable cost paper is again applicable to the Chinese National Standard (CNS) A4 specifications (210 X 297 mm). 6. Applying for a patent Fan Garden A7 B7 C7 D7 0 Permitted I: rationalizing or combining items 1 Fan Li specially requested Φ according to the root of the use of phlegm to eliminate the use of pseudo-salt into the plus 0 allowable rationale 0 or the combination of the other items of the garden Fan Li Zhuan Φ according to root or sexually transmitted diseases and Yan Jieguan 0 Therapeutic wind treatment C is based on the use of phlogritis, which is slower than that of slow use.合 化 ¾Contains * ※ Like, ® Μ or physical epidemic is as small as reasonably slow ia tt ^ ^ SM plus ^ such as * non 1 $ | to accept or receive Fan Li C, please read the precautions on the f side before writing (This page) 0 shape or \ and 0 release dilute can be received and received 1- * rational 0 6Ε a more or species combined below —裝. 訂. 中 式 經濟部中央標準局S工消费合作社印製 範 , 利子 專原 請氫 申為 據各 根 甲 及 子 原 氯 是 R7不—Installation. Order. Printed by Chinese Industrial and Commercial Cooperatives, Central Standards Bureau of the Ministry of Economic Affairs, Lizi Special, please apply for hydrogen. According to the root and chlorine, the chlorine is R7. 述 所 中 項 X 如Item X in the statement 及但 6 > R述 ’所 R3中 本紙張尺度適用中國國家標準(CNS)甲4规格(210 X 297公釐) .綿.And Dan 6 > R narration ’So R3 in this paper scale is applicable to China National Standard (CNS) A 4 specifications (210 X 297 mm).
TW080109166A 1990-10-30 1991-11-22 TW202427B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023535A GB9023535D0 (en) 1990-10-30 1990-10-30 Chemical compounds
GB919105516A GB9105516D0 (en) 1990-10-30 1991-03-15 Chemical compounds

Publications (1)

Publication Number Publication Date
TW202427B true TW202427B (en) 1993-03-21

Family

ID=10684539

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080109166A TW202427B (en) 1990-10-30 1991-11-22

Country Status (8)

Country Link
KR (1) KR100211480B1 (en)
GB (2) GB9023535D0 (en)
MD (1) MD901C2 (en)
RU (1) RU2073667C1 (en)
TW (1) TW202427B (en)
UA (1) UA26393A (en)
YU (1) YU48688B (en)
ZA (1) ZA918633B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546271A1 (en) * 1975-10-16 1977-04-28 Hoechst Ag Fungicides contg. substd. cyano-acetanilide derivs. - esp. as seed dressings against Helminthosporium gramineum of barley
DE2555789A1 (en) * 1975-12-11 1977-07-07 Hoechst Ag Antiinflammatory and analgesic hydroxy-methylene-cyano-acetanilides - prepd. e.g. by reacting cyanoacetanilide derivs. with ortho-esters and hydrolysing
DE2557003A1 (en) * 1975-12-18 1977-06-23 Hoechst Ag Hydroxyethylidene-cyano-acetanilides - with antiinflammatory and analgesic activity
DE2555685A1 (en) * 1975-12-11 1977-06-23 Hoechst Ag Hydroxyethylidene-cyano-acetanilides - with antiinflammatory and analgesic activity
DE3669709D1 (en) * 1985-05-22 1990-04-26 Rhone Poulenc Chimie METHOD FOR PERFLUORALCYLATING AROMATIC DERIVATIVES.
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles

Also Published As

Publication number Publication date
ZA918633B (en) 1992-12-30
YU173191A (en) 1994-04-05
UA26393A (en) 1999-08-30
GB9023535D0 (en) 1990-12-12
YU48688B (en) 1999-07-28
RU2073667C1 (en) 1997-02-20
KR100211480B1 (en) 1999-08-02
KR920007986A (en) 1992-05-27
MD901C2 (en) 1998-09-30
MD901B2 (en) 1998-01-31
GB9105516D0 (en) 1991-05-01

Similar Documents

Publication Publication Date Title
JP3023098B2 (en) Novel 3-aminopyrazolo [1,5-a] pyrimidine, keratin fiber dyeing composition containing the same, and dyeing method using the same
US6727392B2 (en) Process for the preparation of non-steroidal glucocorticoid receptor modulators
JPS5899471A (en) Novel preparation of benzothiazepin derivative
JP2007514638A5 (en)
TW323276B (en)
TW202427B (en)
TW492959B (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
TW203606B (en)
US3449349A (en) Certain 4-(2,3,or 4-pyridyl)-phenylacetic acid and derivatives thereof
CN103086963A (en) Synthetic method of flupirtine maleate A-type crystal compound and midbody
Muzalevskiy et al. Synthesis of α-trifluoromethyl-phenethylamines from α-trifluoromethyl β-aryl enamines and β-chloro-β-(trifluoromethyl) styrenes
JPH03153680A (en) Biphenyl compound and its preparation
JPS60214765A (en) Synthesis of catecholamine derivative hydrochloride
JPH03157354A (en) Production of carboxyalkyl-substituted hydroxylamines
JPS604818B2 (en) Novel 2,6-bis(alkylamino)pyridine or salt thereof and method for producing them
JPS6227063B2 (en)
JP2606184B2 (en) Method for producing novel 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine
CA1045135A (en) Pyrrolo(3,4-d)pyrimidines and methods for their preparation
JPS59157097A (en) Alpha,alpha-trehalose fatty acid tetraester derivative and its preparation
CN101024619B (en) Method for synthesizing N-substituted O-bromobenzylacidamide
JPS6028957A (en) Ester derivatives of indolylacetic acid and phenylacetic acid and their production
JP2023539043A (en) Benzylamine derivatives, their preparation methods and their uses
SU697508A1 (en) Method of preparing 2-hydroxy-5-nitropyridine
TW213443B (en)
JPH01224359A (en) Production of 5-substituted indoles

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent